| Sopharma Buildings to invest 14.6 mln euro in Sofia residential development
Newly set up real estate investment trust Sopharma Buildings will invest 14.6 mln euro in a housing development in Sofia, shows the IPO prospectus of the company that has been approved by the local financial regulator. The project should be completed in 36 months. Sopharma Buildings plans to finance its business with two capital raises by the end of 2008. After the law-prescribed 150,000 lev hike, the company plans a 5 mln lev increase by the end of Q1 and a third increase by the end of Q4. Source: Dnevnik (11.01.2008) |
| The General Meeting of the shareholders of Sofarma building REIT - Sofia, Bourse code SFBLD, which was held on May 27, 2008, decided that the company should not distribute dividends for 2007. Sofarma building REIT - Sofia reported loss to the amount of BGN 20 000. Source: Capital market (29.05.2008) |
| Sopharma Buildings and BGI Group shares started trading on June 25
Shares emissions of BGI Group and Sopharma Buildings REIT will be introduced for trading on the Bulgarian Stock Exchange on Wednesday (26 June), according to a release of the Exchange. The emission of Sopharma Buildings is divided into 649,990 shares with nominal value of BGN 1. The bourse code is 4OX. The Sopharma Buildings investment of money, securities raised by issuing, real estate (real estate securitisation), etc. The emission of BGI Group is divided into 9 mln shares with nominal value of BGN 1 as well. The bourse code is BOH. The BGI Group line of business is purchase and sale of real estates, trade representation and intermediation, etc. Source: Darik Radio (13.06.2008) |
| Sopharma JSC bought 71 500 new shares of the capital of Sofarma bilding REIT. Thus the direct participation of the pharmaceutical manufacturer has reached 40.72% of the capital of the company with a special investment purpose, and the total is 99.72%. The scope of activity of Sofarma bilding REIT involves investment of money raised by issuing securities, in real estate through purchase of property right and other rights on real estates. Source: Banker (13.08.2008) |
| Only for a day the blue-chip Sofix lost the positions it gained the previous three days. The bears bit 5.08% from it to 604.97 points. The other indexes followed the tendency. BGREIT of real estate investment trusts dipped the least by 2.10% to 61.42 basis points. The broad BG40 of the most traded stocks lost 2.60% to 161.28 points and BGTR30 of the best performers in total return dropped by 4% to 421.44 points. Source: Pari (23.10.2008) |
| Sopharma Buildings REIT - Sofia, Bourse code 4OX, the annual general meeting of which was held on May 26, 2009, will not distribute dividends for the year 2008. Sopharma Buildings REIT - Sofia reported a loss for 2008 in the amount of BGN 25 000. Source: Capital market (28.05.2009) |
| The General Meeting of the shareholders of Sopharma Buildings REIT-Sofia, Bourse code 4OX, which was held on June 10, 2010, decided to distribute gross dividend for 2009 of BGN 0.0016 per share. Source: Capital market (14.06.2010) |
| Bulgarian drug maker Sopharma said on Thursday it bought back 11,210 of its shares for a total 35,719 levs between June 20 and 26. The repurchased equity represents a 0.008% stake in the company. The company paid 3.19 levs per share on average. Sopharma has already bought back 4.4 million own shares, representing 3.34% of its equity. Source: profit.bg (28.06.2013) |
| Bulgaria's Unipharm plans to pay EUR 0.05 per share in gross dividend
Bulgarian drug maker Unipharm plans to pay a gross dividend of BGN 0.09 per share for 2013, it said on Tuesday. The company’s shareholders will vote the decision at a general meeting to be held on June 18, Unipharm said in a bourse filing. Unipharm will distribute as a dividend a total of BGN 540,000 of its BGN 728,000 profit, after allocating 10% of the profit or some BGN 72,800 as legal reserve, while the rest of it will be set aside for additional reserves. The drug maker distributed a gross dividend of BGN 0.05 per share for 2012. Source: Capital (14.05.2014) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial website http://www.x3news.com/displayNovina.jsp?formid=121135 Source: BSE (31.07.2018) |
| Sopharma Properties REIT-Sofia (6S6)
Notification by Donev Investments Holding AD under Art. 19 of Regulation (EU) No. 596/2014 of the European Parliament and the Council of 16 April 2014 (market abuse regulation) - secondary publishing. Source: BSE (12.09.2018) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial website http://www.x3news.com/displayNovina.jsp?formid=122904 Source: BSE (31.10.2018) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial web-site http://www.x3news.com/displayNovina.jsp?formid=124999 Source: BSE (31.01.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial website http://www.x3news.com/displayNovina.jsp?formid=126527 Source: BSE (01.04.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial website http://www.x3news.com/displayNovina.jsp?formid=127521 Source: BSE (02.05.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
BSE has received the materials of the regular General Meeting of Shareholders of Sopharma Buildings REIT-Sofia (4OX) as follows:
Sopharma Buildings REIT has appointed a General Meeting of Shareholders on 11 June 2019 at 3:00 p.m. in the city of Sofia at 5 Lachezar Stanchev St., Sopharma Business Towers, Building A, floor 20, under the following agenda:
- Report of the managing bodies on the company's activity in 2018
- Adoption of the 2018 annual financial report of the company
- Report of the registered auditor on the 2018 audit
- Report of the Audit Committee
- Report of the Investor Relations Director
- Election of a registered auditor
- Release from liability of the members of the managing bodies with respect to their activity in 2018
- Financial result allocation decision
Draft resolution: No dividend distribution for 2018 due to a negative financial result
- Determination of the remuneration to the members of the managing bodies in 2019
- Report on the implementation of the remuneration policy for the members of the managing bodies
- In the absence of a quorum, the GMS will be held on 26 June 2019 at 3:00 p.m., at the same place and under the same agenda.
The voting right will be entitled to all shareholders registered with the Central Depository fourteen (14) days prior to the GMS date, i.e. by 28 May 2019 (Record Date).
The final date for transacting shares of this company on the BSE, as a result of which the holders will be entitled to exercise their voting right at the GMS, will be 23 May 2019 (Ex Date: 27 May 2019). Source: BSE (03.05.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
Sopharma Buildings REIT has submitted a copy of the publication of the notice of appointment of the regular General Meeting of Shareholders which will be held on 11 June 2019 at 3:00 p.m. in the city of Sofia at 5 Lachezar Stanchev St., Sopharma Business Towers, Building A, floor 20. Source: BSE (03.05.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
Sopharma Buildings REIT hereby informs the public of the financial result allocation decision adopted by the General Meeting of Shareholders of the company held on 11 June 2019, namely:
- Approval of the Board of Directors' proposal, no dividend to be distributed for 2018 due to a reported negative financial result in the amount of BGN 70,555.45, which shall be covered by funds of the reserves from the share premium account
The Record of Proceedings taken at the company's GMS will be announced within the statutory period. Source: BSE (13.06.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
The General Meeting of Shareholders of Sopharma Buildings REIT dated 11 June 2019 has passed the following resolutions:
- Adoption of the 2018 activity report of the managing bodies
- Adoption of the 2018 annual financial report of the company
- Adoption of the report of the specialised audit firm on the verification of the 2018 annual financial report of the company
- Election of a registered auditor
- Adoption of the report of the Audit Committee
- Adoption of the report of the Investor Relations Director
- Release from liability of the members of the managing bodies with respect to their activity in 2018
- No dividend distribution for 2018 due to a reported negative financial result in the amount of BGN 70,555.45, which shall be covered by funds of the reserves from the share premium account
- Adoption of the report on the implementation of the remuneration policy for the members of the managing bodies
- Determination of the remuneration to the members of the managing bodies in 2019 Source: BSE (17.06.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial website http://www.x3news.com/displayNovina.jsp?formid=130681 Source: BSE (31.07.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial website http://www.x3news.com/displayNovina.jsp?formid=133087 Source: BSE (31.10.2019) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial web-site X3News Source: BSE (31.01.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
Sopharma Buildings REIT has acquired a real estate in the town of Burgas. Source: BSE (07.02.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
Sopharma Buildings REIT has resubmitted to BSE the notification regarding the acquired real estate in the town of Burgas with a corrected clerical error. Source: BSE (10.02.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial web-site X3News Source: BSE (31.03.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial web-site X3News Source: BSE (04.05.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
Sopharma Buildings REIT has submitted a copy of the publication of the notice of appointment of the regular General Meeting of Shareholders which will be held on 16 June 2020 at 3:00 p.m. in the city of Sofia at 5 Lachezar Stanchev St., Sopharma Business Towers, Tower A, floor 20.
The entire piece of news is published on the financial website X3News. Source: BSE (14.05.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
BSE has received the materials of the regular General Meeting of Shareholders of Sopharma Buildings REIT-Sofia (4OX) as follows:
Sopharma Buildings REIT has appointed a General Meeting of Shareholders on 16 June 2020 at 3:00 p.m. in the city of Sofia at 5 Lachezar Stanchev St., Sopharma Business Towers, Tower A, floor 20, under the following agenda:
- Report of the managing bodies on the company's activity in 2019
- Adoption of the 2019 annual financial report of the company
- Report of the registered auditor on the 2019 audit
- Report of the Audit Committee
- Report of the Investor Relations Director
- Election of a registered auditor
- Release from liability of the members of the managing bodies for their activity in 2019
- Financial result allocation decision
Draft resolution: No dividend distribution for 2019 due to a negative financial result
- Re-election of the members of the Audit Committee for a new term and determination of their remuneration
- Changes within the managing bodies of the company
Draft resolution: Release of Ivan Kralev from the position of a member of the Board of Directors and election of Stoycho Pangev as a new member of the Board for a term of five (5) years;
Re-election of the other two members, Emil Kostov and Irina Mincheva, for a new term of five (5) years
- Determination of the 2020 remuneration to the members of the managing bodies as well as the guarantee for the management
- Report on the implementation of the remuneration policy for the members of the managing bodies
- In the absence of a quorum, the GMS will be held on 01 July 2020 at 3:00 p.m., at the same place and under the same agenda.
The voting right will be entitled to all shareholders registered with the Central Depository fourteen (14) days before the GMS i.e. by 02 June 2020 (Record Date).
The final date for transacting shares of this company on the Exchange, as a result of which the holders will be entitled to exercise their voting right at the GMS, will be 29 May 2020 (Ex Date: 01 June 2020).
The entire invitation is available on the website of the Exchange.
The entire piece of news is published on the financial website X3News. Source: BSE (14.05.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The company notifies of the decisions of greater importance as passed by the regular GMS held on 16 June 2020:
- Adoption of the 2019 annual financial report of the company
- No dividend distribution for 2019 due to a reported negative financial result in the amount of BGN 80,026.05, which shall be covered by funds of the reserves from the share premium account
The entire piece of news is published on the financial website X3News. Source: BSE (18.06.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The General Meeting of Shareholders of Sopharma Buildings REIT dated 16 June 2020 has passed the following resolutions:
- Adoption of the 2019 activity report of the managing bodies
- Adoption of the 2019 annual financial report of the company
- Adoption of the report of the specialised audit firm on the verification of the 2019 annual financial report of the company
- Election of a registered auditor
- Adoption of the report of the Audit Committee
- Adoption of the report of the Investor Relations Director
- Adoption of the report on the implementation of the remuneration policy for the members of the managing bodies
- Release from liability of the members of the managing bodies for their activity in 2019
- Re-election of the members of the Audit Committee for a new term and determination of their remuneration
- Changes within the managing bodies of the company:
Release of Ivan Kralev from the position of a member of the Board of Directors and election of Stoycho Pangev as a new member of the Board for a term of five (5) years;
Re-election of the other two members, Emil Kostov and Irina Mincheva, for a new term of five (5) years;
Determination of the 2020 remuneration to the members of the managing bodies as well as the guarantee for their management
- No dividend distribution for 2019
- Adoption of a decision the 2019 loss of BGN 80,026.05 to be covered by the share premium reserve of the company
The Record of Proceedings taken at the company's GMS is available on the website of the Exchange.
The entire piece of news is published on the financial website X3News. Source: BSE (23.06.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
Sopharma Buildings REIT entered in the Commercial Register the re-election of the members of the Board for a new term of five (5) years.
The entire piece of news is posted on the financial website X3News. Source: BSE (26.06.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial web-site X3News Source: BSE (31.07.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
BSE has received the materials of the extraordinary General Meeting of Shareholders of Sopharma Buildings REIT-Sofia (4OX) as follows:
Sopharma Buildings REIT has appointed a General Meeting of Shareholders on 24 September 2020 at 3:00 p.m. in the city of Sofia at 5 Lachezar Stanchev St., Sopharma Business Towers, Tower A, floor 20, under the following agenda:
- Adoption of a new remuneration policy for the members of the managing bodies
- In the absence of a quorum, the GMS will be held on 12 October 2020 at 3:00 p.m., at the same place and under the same agenda.
The voting right will be entitled to all shareholders registered with the Central Depository fourteen (14) days before the GMS i.e. by 10 September 2020 (Record Date).
The final date for transacting shares of this company on the Exchange, as a result of which the holders will be entitled to exercise their voting right at the GMS, will be 08 September 2020 (Ex Date: 09 September 2020). Source: BSE (24.08.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
Sopharma Buildings REIT has submitted a copy of the publication of the notice of appointment of the extraordinary General Meeting of Shareholders which will be held on 24 September 2020 at 3:00 p.m. in the city of Sofia. Source: BSE (24.08.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The extraordinary General Meeting of Shareholders of Sopharma Buildings REIT dated 24 September 2020 has passed the following resolution:
- Adoption of a new remuneration policy for the members of the managing bodies Source: BSE (28.09.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial web-site X3News Source: BSE (02.11.2020) |
| Sopharma Buildings REIT-Sofia (4OX)
The report can be found on the financial web-site X3News Source: BSE (01.02.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
The report can be found on the financial web-site X3News Source: BSE (31.03.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
The report can be found on the financial web-site X3News Source: BSE (05.05.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
Shareholding disclosure notification under Art. 148b of the POSA Source: BSE (08.06.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
Shareholding disclosure notification under Art. 148b of the POSA Source: BSE (10.06.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
Shareholding disclosure notification under Art. 148b of the POSA Source: BSE (16.06.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
The regular General Meeting of Shareholders of Sopharma Buildings REIT dated 24 June 2021 has passed the following resolutions:
- Adoption of the 2020 activity report of the managing bodies
- Adoption of the 2020 annual financial report of the company
- Adoption of the report of the registered auditor on the verification of the 2020 annual financial report of the company
- Adoption of the report of the Audit Committee
- Adoption of the report of the Investor Relations Director
- Adoption of the report on the implementation of the remuneration policy for the members of the managing bodies
- Release from liability of the members of the managing bodies for their activity in 2020
- Election of a registered auditor
- Amendments to the Statutes of the company
- Allocation of the 2020 profit of BGN 76,311.17 to the Reserve Fund of the company
- Fixing the 2021 monthly remuneration to the members of the Board of Directors
- Amendments to the remuneration policy for the members of the managing bodies
- Amendments to the scope of business activity of the company Source: BSE (28.06.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
The report can be found on the financial web-site X3News Source: BSE (29.07.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
The report can be found on the financial web-site X3News Source: BSE (01.11.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
Ivanka Panova, Investor Relations Director of Sopharma Buildings REIT, has a new e-mail: v.panova@sbt.bg
The entire piece of news may be accessed via the financial website X3News. Source: BSE (14.12.2021) |
| Sopharma Buildings REIT-Sofia (SFB)
The report can be found on the financial web-site X3News Source: BSE (01.02.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
The report can be found on the financial web-site X3News Source: BSE (24.03.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
The report can be found on the financial web-site X3News Source: BSE (03.05.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT presented a copy of the publication of the invitation to the regular General Meeting of Shareholders to be held on 16 June 2022 at 3:00 pm in the city of Sofia.
The entire piece of news is published on the financial website X3News. Source: BSE (10.05.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT has appointed a regular General Meeting of Shareholders on 16 June 2022 at 3:00 pm in the city of Sofia at 5 Lachezar Stanchev St., Sopharma Business Towers, Tower A, floor 20, under the following agenda:
- Report of the managing bodies on the company's activity in 2021
- Adoption of the 2021 annual financial report of the company
- Report of the registered auditor on the 2021 audit
- Report of the Audit Committee on 2021
- Report of the Investor Relations Director on 2021
- Report on the implementation of the remuneration policy for the members of the managing bodies
- Release from liability of the members of the managing bodies for their activity in 2021
- Election of a registered auditor for 2022
- Financial result allocation decision
Draft resolution: No dividend distribution for 2021 and allocation of the 2021 profit of BGN 4,571.23 to the Reserve Fund
- Fixing the 2022 monthly remuneration to the members of the Board of Directors
- In the absence of a quorum, the GMS will take place on 01 July 2022 at 3:00 pm, at the same place and under the same agenda.
The voting right will be entitled to all shareholders registered with the central securities register fourteen (14) days before the GMS, i.e. by 02 June 2022 (Record Date).
The final date for transacting shares of this company on the Exchange, as a result of which the holders will be entitled to exercise their voting right at the GMS, will be 31 May 2022 (Ex Date: 01 June 2022).
The invitation is available on the website of the Exchange.
The entire piece of news is published on the financial website X3News. Source: BSE (10.05.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification by Sopharma Buildings REIT about the regular General Meeting of Shareholders held today, 16 June 2022
The entire piece of news is posted on the financial website X3News. Source: BSE (17.06.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia presented a quarterly report for the Second Quarter of 2022. Source: BSE (01.08.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia presented a quarterly report for the Third Quarter of 2022. Source: BSE (01.11.2022) |
| Sopharma Buildings REIT-Sofia (SFB)
The Board of Directors of Sopharma Buildings REIT decided at its meeting on 22 December 2022 to increase the company's capital under Art. 196 (1) & Art. 194 (1) of the Commerce Act and Art. 112 et seq. of the POSA from BGN 649,990 up to BGN 3,899,940 through the issuance of new 3,249,950 dematerialised voting shares of BGN 1.00 par value and BGN 1.86 issue price per share.
Everyone may subscribe to as many shares as the number of acquired and/or held rights multiplied by five (5). The capital will be increased by the value of subscribed shares provided at least 1,624,975 shares are subscribed to and paid.
The Board of Directors has authorised Sofia International Securities AD Investment Intermediary to administer the company's capital increase. Source: BSE (23.12.2022) |
| The Financial Supervision Commission (FSC) has approved a prospectus for an initial public offering of shares for a capital increase of Sopharma Buildings REIT. The issue is in the amount of up to 3,249,950 ordinary, registered, freely transferable, non-stock voting shares, with a nominal value of BGN 1 and an issue value of BGN 1.86 each. The FSC has entered the issue, which is in the process of being issued, in the register of public companies and other issuers of securities maintained by the FSC. Source: investor.bg (16.02.2023) |
| Advance Terrafund REIT-Sofia (ATER)
Monthly newsletter of Advance Terrafund REIT for January 2023
The newsletter is available in English on the financial website X3News Source: BSE (16.02.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Following a Board of Directors' decision for an increase in capital of Sopharma Buildings REIT adopted on 22 December 2022 and a subsequent announcement under Art. 89s of the POSA made on 15 February 2023 via the electronic media X3News (www.x3news.com), the website of the issuer (www.sopharma-buildings.com) and of the authorised investment intermediary (www.sis.bg), please, be informed in pursuance of Art. 112b (3) of the POSA, that:
- The right to participate in the capital increase is entitled to all shareholders registered with the central securities register not later than five (5) business days after the date of publication of the public offering notice under Art. 89s (1) of the POSA, i.e. by Wednesday, 22 February 2023 (Record Date).
- The final date for transacting shares of this company on the Exchange, as a result of which the holder will be entitled to take part in the capital increase, will be Monday, 20 February 2023 (Ex Date: 21 February 2023). Source: BSE (17.02.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification of the published public offering prospectus regarding the capital increase of Sopharma Buildings REIT Source: BSE (17.02.2023) |
| Following a Board of Directors' decision for an increase in capital of Sopharma Buildings REIT adopted on 22 December 2022 and a subsequent announcement under Art. 89s of the POSA made on 15 February 2023 via the website of the electronic media x3News (www.x3news.com), please, be informed that the following issue of rights has been admitted to trading on the Subscription Rights Segment of the BSE Main Market by order of the Director of Trading on the grounds of Art. 34 (3) in conjunction with Art. 32 (2) of Part III - Listing Rules of the BSE Rules and Regulations:
- Number of shares before the increase: 649,990
- Number of rights issued: 649,990
- Number of shares offered for subscription: 3,249,950
- Nominal value per share: BGN 1.00
- Issue price per share: BGN 1.86
- Ratio between the rights issued and new shares: 1/5 (right/shares)
- Everyone may subscribe at least to one (1) new share and at most to the number of shares equal to the number of acquired respectively held rights multiplied by 5.
- The capital will be increased if at least 1,624,975 new shares will be subscribed to and paid.
- BSE code assigned to the rights issued: SFB1
- ISIN of the rights issued: BG4000003237
- CFI code of the rights issued: To be additionally announced
- LEI code of the issuer: 8945008OVC497G1T2P47
- Segment MIC: ZBUL
- One trading lot: One (1) right
- Currency of trading: BGN
- The bid and ask orders are to be entered according to LB1 liquidity band in pursuance of the Annex to Commission Delegated Regulation (EU) 2017/588 of 14 July 2016.
- Indicative reference price set for the first trading session: BGN 3.8600
- Starting date of trading in rights on the Exchange: 27 February 2023
- Final date of trading in rights on the Exchange: 10 March 2023
- Starting date of transferring the rights: 27 February 2023
- Final date of transferring the rights: 14 March 2023
- Auction date as per Art. 112b (7) of the POSA: 16 March 2023
- Starting date of subscribing to shares of the increase: 27 February 2023
- Final date of subscribing to shares of the increase: 22 March 2023
- Investment intermediary authorised to administer the capital increase: Sofia International Securities AD
- Bank with which an accumulation account will be opened: KBC Bank Bulgaria EAD
- The right to participate in the capital increase is entitled to all shareholders registered with the central securities register not later than five (5) business days after the date of publication of the public offering notice under Art. 89s (1) of the POSA, i.e. by Wednesday, 22 February 2023 (Record Date).
- The final date for transacting shares of this company on the Exchange, as a result of which the holder will be entitled to take part in the capital increase, has been Monday, 20 February 2023 (Ex Date: 21 February 2023). Source: BSE (22.02.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT appointed an extraordinary General Meeting of Shareholders on 30 March 2023 at 11:00 am in the city of Sofia at 5 Lachezar Stanchev St. under the following agenda:
- Adoption of a justification report of the Board of Directors according to Art. 114a (1) of the POSA on the expedience and terms of a deal under Art. 114 (1), item 1 of the POSA
- Authorisation of the Board of Directors to purchase real estate following Art. 114 (1), item 1 of the POSA under the terms detailed in the justification report of the Board of Directors according to Art. 114a (1) of the POSA
- In the lack of quorum, the EGM will take place on 20 April 2023 at 11:00 am, same place and agenda.
The voting right will be entitled to all shareholders registered with the central securities register fourteen (14) days before the EGM, i.e. by 16 March 2023 (Record Date).
The final date for transacting shares of this company on the Exchange, as a result of which the holders will be entitled to exercise their voting right at the EGM, will be 14 March 2023 (Ex Date: 15 March 2023).
The invitation is available on the website of the Exchange. Source: BSE (27.02.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT presented a copy of the publication of the invitation to the extraordinary General Meeting of Shareholders to be held on 30 March 2023 at 11:00 am in the city of Sofia. Source: BSE (27.02.2023) |
| All unsold rights of "Sopharma Buildings" REIT for the capital increase of the company were traded within the auction, which took place on March 16. 2,205 unsold rights were offered at the auction, against which no shares of the increase were subscribed. The company offered a total of 649,990 rights, each of which gives the right to acquire 5 new shares. The investment intermediary chosen to serve the company's capital increase is "Sofia International Securities" JSC. The company's capital will only be increased if at least 1,624,975 shares are subscribed and paid for, i.e. can be raised between BGN 3.022 million and BGN 6.045 million. Source: investor.bg (17.03.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia publishes the Annual Financial Report for the activities of companies with a special investment purpose - ESEF format as of 12-31-2022. Source: BSE (21.03.2023) |
| All offered shares from Sopharma Buildings capital increase sold
All the offered shares from the capital increase of Sopharma Buildings REIT have been sold. During the subscription period (February 27, 2023 - March 21, 2023), 21 requests to subscribe for shares from the increase were received, of which 4 were from legal entities and 17 from individuals. All 3,249,950 new shares were subscribed and paid for, and their issue value of BGN 6,044,907 was fully paid into the company's collection account. Thus, the company's capital will be increased to almost BGN 6.7 million. Sofia International Securities JSC is an investment intermediary that serves the increase of the company's capital. "Sopharma Buildings" REIT ends 2022 with revenues in the amount of BGN 257 thousand compared to BGN 79 thousand a year earlier, and the profit reaches BGN 179 thousand compared to only BGN 5 thousand in 2021. The increase is determined by a correction of the value of investment properties to BGN 227 thousand at the end of 2022 from BGN 49 thousand at the end of 2021. Rental income is stable at BGN 30 thousand, the same as in 2021 Source: investor.bg (24.03.2023) |
| The capital increase of "Sopharma Buildings" is registered in the Commercial Register. The capital of the company is now in the amount of BGN 3,899,940 after the increase. On March 23, the company announced that it had sold all the offered shares from the capital increase. During the subscription period (February 27, 2023 - March 21, 2023), 21 requests to subscribe for shares from the increase were received, of which 4 were from legal entities and 17 from individuals. The decision to increase the capital of Sopharma Buildings REIT was taken by the board of directors on December 22, 2022. The Financial Supervision Commission (FSC) approved the prospectus for the initial public offering of shares for the increase of the capital of Sopharma Buildings in mid on February. The company offered 3,249,950 ordinary, registered, freely transferable, non-stock voting shares, with a nominal value of BGN 1 and an issue value of BGN 1.86 each. Source: investor.bg (30.03.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification of the entry in the Commercial Register of the capital increase of Sopharma Buildings REIT Source: BSE (30.03.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia (SFB) announces an Extraordinary General Meeting. Source: BSE (31.03.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
The extraordinary General Meeting of Shareholders of Sopharma Buildings REIT dated 30 March 2023 has passed the following resolutions:
- Adoption of a justification report of the Board of Directors according to Art. 114a (1) of the POSA on the expedience and terms of a deal under Art. 114 (1), item 1 of the POSA
- Authorisation of the Board of Directors to purchase real estate following Art. 114 (1), item 1 of the POSA under the terms and conditions detailed in the justification report of the Board of Directors according to Art. 114a (1) of the POSA Source: BSE (03.04.2023) |
| "Sopharma Buildings" buys the base of "Unipharm" in Sofia from "Sopharma"
"Sopharma Buildings" REIT buys from "Sopharma" AD a property on "St. Kliment Ohridski" and "Traiko Stanoev" street opposite HTMU, in "Darvenica" district in Sofia. The price of the transaction is BGN 6,337,350, as can be seen from the minutes of the general meeting of shareholders, which took place on March 30. Shareholders have approved the deal. In the same complex was the production and warehouse base of Unifarm, which merged into Sopharma. Sopharma Buildings recently raised capital because of the deal. The capital of the company is now in the amount of BGN 3,899,940 after the increase, after selling all the proposed shares from the increase. Source: investor.bg (03.04.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification of a decision ¹ 425-E/04.04.2023 of the FSC for registering an issue of shares of 3,249,950 new ordinary registered freely transferable dematerialised and voting shares of BGN 1.00 nominal value per share as a result of the capital increase of Sopharma Buildings REIT from BGN 649,990 to BGN 3,899,940 Source: BSE (05.04.2023) |
| BSE has received an application for admission to trading of a subsequent issue of shares as follows:
- Issuer: Sopharma Buildings REIT-Sofia
- ISIN of the issue: BG1100084075
- BSE code of the issue: SFB
- Amount of the issue before the increase: BGN 649,990
- Amount of the increase: BGN 3,249,950
- Amount of the issue following the increase: BGN 3,899,940
- Number of shares following the increase: 3,899,940
- Nominal value per share: BGN 1.00 /one Bulgarian lev/ Source: BSE (05.04.2023) |
| At a meeting of the Board of Directors of BSE AD under Minutes No. 17/06.04.2023, the following decision was taken:
In connection with the Decision of the FSC No. 425 - E of 04.04.2023 regarding the entry of a subsequent issue of shares in the register of public companies and other issuers of securities under Art. 30, para. 1, item 3 of ZKFN, led by KFN, the Board of Directors of BSE AD, on the basis of Art. 33, para. 8, in connection with Art. 19 of Part III Rules for admission to trading, admission to trading of Segment shares on the Alternative Market BàSE subsequent issue of shares, as follows:
- Issuer: Sopharma Buildings REIT-Sofia;
- ISIN code of the issue: BG1100084075;
- Exchange code of the issue: SFB;
- Size of the issue before the increase: BGN 649,990;
- Amount of the increase: BGN 3,249,950;
- Amount of the issue after the increase: BGN 3,899,940;
- Number of shares after the increase: 3,899,940 shares;
- Nominal value of one share: BGN 1.00 (one).
- Type of shares: ordinary, registered, non-present with voting rights;
- Date of introduction for trading: 11.04.2023 (Tuesday). Source: BSE (07.04.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification of the decision of the BSE Board of Directors to admit to trading on the Exchange a subsequent issue of shares following the capital increase of Sopharma Buildings REIT Source: BSE (10.04.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification under Art. 112e of the POSA of a change to Sopharma Buildings REIT capital in March 2023 Source: BSE (19.04.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia presented a quarterly report for the First Quarter of 2023. Source: BSE (02.05.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT presented a copy of the publication of the invitation to the regular General Meeting of Shareholders to be held on 09 June 2023 at 2:00 pm in the city of Sofia. Source: BSE (04.05.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia (SFB) convenes a regular AGM on 06/09/2023 at 2:00 p.m. in the city of Sofia, 5 Lachezar Stanchev St., Sopharma Business Towers, Building A, floor 20, with the following agenda:
- Report of the management bodies on the company's activities in 2022;
- Adoption of the company's annual financial report for 2022;
- Report of the registered auditor for 2022;
- Report of the Audit Committee for 2022;
- Report of the Director of Investor Relations for 2022;
- Acceptance of a report on the implementation of the Policy on the remuneration of the members of the governing bodies;
- Release of the members of the governing bodies from responsibility for their activities in 2022;
- Election of a registered auditor for 2023;
- Re-electing the members of the Audit Committee for a new mandate and determining their remuneration;
- Changes in the company's statutes;
- Decision on distribution of financial result. Draft decision: No dividend for 2022. The generated profit for 2022, in the amount of BGN 178,515.42, to be transferred to the Reserve fund;
- Determining the amount of remuneration of the members of the governing bodies.
- In the absence of a quorum, the meeting will be held on 26.06.2023 at 2 p.m. at the same place and with the same agenda.
The right to vote in the General Meeting of Shareholders is exercised by the persons registered as such with the right to vote in the central register of securities 14 days before the date of the General Meeting of Shareholders, or as of 26.05.2023.
The last date for concluding transactions with shares of this company on the Stock Exchange, as a result of which the acquirer will be able to exercise the right to vote in the General Meeting of Shareholders, is 23.05.2023. Source: BSE (04.05.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification of the regular General Meeting of Shareholders held on 09 June 2023 Source: BSE (13.06.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
The regular General Meeting of Shareholders of Sopharma Buildings REIT dated 09 June 2023 passed the following resolutions:
- Adoption of the 2022 activity report of the managing bodies
- Adoption of the 2022 annual financial report of the company
- Adoption of the report of the registered auditor on the verification of the 2022 annual financial report
- Adoption of the report of the Audit Committee on 2022
- Adoption of the report of the Investor Relations Director on 2022
- Adoption of the report on the implementation of the remuneration policy for the members of the managing bodies
- Release from liability of the members of the managing bodies for their activity in 2022
- Election of a registered auditor for 2023
- Re-election of the members of the Audit Committee for a new term of office and fixing their remuneration
- Amendments to the Statutes of the company
- No dividend distribution for 2022 and allocation of the 2022 profit of BGN 178,515.42 to the company's reserves
- Determination of the remuneration to the members of the managing bodies Source: BSE (14.06.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
The company disclosed information regarding a deal under Art. 114 (1), item 1 of the POSA. Source: BSE (15.06.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT publishes a notification under Art. 114, para. 1, item 1 of the POSA. Source: BSE (16.06.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification regarding registered changes in the company's articles of association. Source: BSE (23.06.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia presented a quarterly report for the Second Quarter of 2023. Source: BSE (31.07.2023) |
| "Sopharma Buildings" will build a residential complex opposite the Technical University in Sofia
"Sopharma Buildings" plans to build a residential complex on the site of the former buildings of the Scientific Research Chemical and Pharmaceutical Institute (NIHFI) and "Unipharm", which are located opposite the Technical University in Sofia and not far from the office towers of "Sopharma". "Sopharma Buildings" has revenues of less than BGN 1 million. At the beginning of this year, however, its capital was increased, and at the end of March it bought from "Sopharma" the land of its former subdivisions - NIHFI and "Unifarm" for 6.337 million without VAT. The assessment states that the land has a total area of 17,688 sq.m., and a maximum building height of 20m and a density of less than 60% is permitted in the area. Since a key infrastructure passes through the land in "Darvenica", near Studentski Grad, it is not possible to use the entire area for construction. "Sopharma Buildings" will directly sell the built apartments in the complex, and will not rent them out. Since the decision to purchase the land, the price of the company's shares has more than doubled and reached BGN 17.60. The revenues of "Sopharma" for the half year increased by 13.4% compared to the same period last year and reached BGN 125 million. BGN, and the net profit for the period jumped by 57.2% to BGN 37.1 million. Last year was also extremely good for the pharmaceutical company. It ended with a profit of nearly BGN 40 million, which was fully distributed as a dividend of 60 cents per share. Source: Dnevnik (08.08.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification of a decision of the Board of Directors of Sopharma Buildings REIT on a specific order assignment pursuant to an annex concluded to the existing agreement for performance of activities as a third party under Art. 27 (4) of the SPICCSA Source: BSE (08.08.2023) |
| FSC approved the project for a residential complex in the former base of "Unifarm"
The Financial Supervision Commission (FSC) has approved the design and construction contract between "Sopharma Buildings" REIT and "Telekomplekt" AD, which complements the contract between the two companies for carrying out activities as a service company of "Telekomplekt" from September 2007. With approvals a contract has been awarded for the engineering for the construction of the site of the former production and warehouse base of "Unifarm" in the "Darvenitsa" district in Sofia. Sopharma Buildings acquired the property, located at 3 Kliment Ohridski Blvd., from Sopharma in the spring. Sopharma Buildings increased its capital for the transaction. The old buildings were demolished and the grounds were cleared in April-May this year. "Sopharma Buildings" announced at the beginning of the week that a residential complex with garages and serving commercial areas will be built on the site. The total built-up area is expected to be around 45 thousand sq.m. The estimated value of the investment in the complex is EUR 30 million without VAT. Source: investor.bg (14.08.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Notification that the Financial Supervision Commission approved a design and construction agreement signed between Sopharma Buildings REIT and Telecomplect AD on 07 August 2023 for amending and supplementing the service agreement signed by both parties on 14 September 2007 and assigning the engineering of a construction on a site owned by Sopharma Buildings REIT Source: BSE (14.08.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Corrected share participation disclosure notification under Art. 148b of the POSA. Source: BSE (07.09.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Share participation disclosure notification under Art. 148b of the POSA. Source: BSE (07.09.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Share participation disclosure notification under Art. 148b of the POSA. Source: BSE (08.09.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Share participation disclosure notification Source: BSE (11.09.2023) |
| At a meeting of the Committee on Indices at BSE AD, according to Protocol No. 8 of 11.09.2023, the following decisions were taken:
III. In connection with item 8 of Appendix No. 3 (Calculation Methodology of BG REIT) to the Rules for Calculation of Indices of the Bulgarian Stock Exchange, the Commission on Indices determines the following free-float coefficients of the issues included in the base of BG REIT, which will enter into force as of 18.09.2023:
Stock code Issuer Free-float coefficient
ATER Advance Terafund REIT-Sofia 0.6112
BSP Balkan & Sea Properties REIT-Varna 0.3954
RPF Roy Property Fund REIT-Sofia 0.3843
SFB Sopharma Buildings REIT-Sofia 0.3003
SBPF Super Borovets Property Fund REIT-Burgas 0.6458
BREF Real Estate Fund Bulgaria REIT-Sofia 0.7429
CCBR CCB Real Estate Fund REIT-Sofia 0.5093
The free-float data of BG REIT's issues is a median value for the period from 02.06.2023 to 01.09.2023.
IV. In relation to item 15 of the Rules for calculating the index of companies with good corporate governance CGIX, the Indices Commission determines the following free-float coefficients of the issues included in the CGIX base, which will come into force as of 18.09.2023 year:
Stock code Issuer Free-float coefficient
ALB Albena AD-k.c. Albena 0.2993
BSE Bulgarian Stock Exchange AD-Sofia 0.4995
IHB Industrial Holding Bulgaria AD-Sofia 0.2198
KBG Corrado-Bulgaria AD-Strazitsa 0.1785
MONB Monbat AD-Sofia 0.1733
SFA Sopharma AD-Sofia 0.2885
CHIM Chimimport AD-Sofia 0.2210
Data on free-float issues from CGIX are as of 09/01/2023.
V. In relation to item 20 of the Rules for calculating an index of companies on the beam (beamX) market, the Indices Commission determines the following free-float coefficients for the issues included in the beamX base, which will come into force as of 18.09 .2023:
Stock code Issuer Free-float coefficient
AMON AmonRa Energy AD-Sofia 0.0482
BEE BEE Smart Technologies AD-Sofia 0.2596
BDT Biodit AD-Sofia 0.1741
DRON Dronamix Capital AD-Sofia 0.9165
HRC HR Capital AD-Sofia 0.1805
IMP Impuls I AD-Sofia 0.8557
MFG MFG Invest AD-Sofia 0.1107
SIN Sin Cars Industry AD-Sofia 0.1228
SO Smart Organic AD-Sofia 0.0365
WIN Webit Investment Network AD-Varna 0.8546
Free-float emission data from beamX is a median value for the period 06/02/2023 to 09/01/2023.
VI. The Commission on Indices will determine the weight coefficients of the issues included in the bases of the BSE indices (including in the index of companies on the beam market) and the CGIX index based on the respective "close" prices as of 09/15/2023.
VII. The next meeting of the Indices Commission, at which the free-float coefficients of the issues included in the BSE indices (including the beam market companies index) and the CGIX index will be determined, will be held on 04.12.2023 y., and these coefficients will come into force starting from 18.12.2023. Source: BSE (12.09.2023) |
| At a meeting held by the Board of Directors of the BSE under Protocol No. 49 of 11.09.2023, the following decisions were taken:
II. Revision based on BGBX 40
Pursuant to Art. 15, item 4 of the BSE Index Calculation Rules in connection with item 15 of Appendix No. 2 (Methodology for BGBX 40 calculation), the Board of Directors excludes the following six issues of shares from the base of the BGBX 40 index:
THQM Chaikapharma High-quality medicines AD-Sofia;
SFI Sofarma properties REIT-Sofia;
FZLS Phaserless AD-Silistra;
ELHM Elhim Iskra AD-Pazardzhik;
BSP Balkan and Sea Properties REIT-Varna; and
BRP Shipping Bulgarian River Navigation AD-Ruse;
and adds the following six share issues to the base of the BGBX 40 index:
BPF Bravo Property Fund REIT-Sofia;
T57 Trace Group Hold AD-Sofia;
GTH Investment Company Galata AD-Varna;
HNVK Holding Nov Vek AD-Sofia;
HRZ Rodna Zemya Holding AD-Sofia; and
HIKA Industrial Capital Holding AD-Sofia.
III. Basis Revision of BG REIT
Pursuant to Art. 15, item 4 of the BSE Index Calculation Rules in connection with item 12 of Appendix No. 3 (Calculation Methodology of BG REIT), the Board of Directors excludes the following issue of shares from the base of the BG REIT index:
ICPD Intercapital Property Development REIT-Sofia;
and adds the following issue of shares to the base of the BG REIT index:
SFB Sopharma Buildings REIT-Sofia.
IV. Revision based on BG TR30
Pursuant to Art. 15, item 4 of the Rules for calculating BSE indices in connection with item 17 of Appendix No. 4 (Methodology for calculating BG TR30), the Board of Directors excludes the following four share issues from the basis of the BG TR30 index:
SFI Sopharma Real Estate REIT-Sofia,
MONB Monbat AD-Sofia,
FIB TB First Investment Bank AD-Sofia, i
ALB Albena AD-k.c. Albena;
and adds the following four share issues to the base of the BG TR30 index:
TBS Telelink Business Services Group AD-Sofia,
HNVK Holding Nov Vek AD-Sofia,
CHSB Himsnab Bulgaria AD-Sofia, i
HSOF Holding Sveta Sofia AD-Sofia.
Decisions to change the base of the BGBX 40, BG REIT and BG TR30 indices shall come into force as of the first trading session after the third Friday of the month in which the relevant meeting was held, or in the specific case of September 18, 2023. Source: BSE (12.09.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Share participation disclosure notification Source: BSE (14.09.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Share participation disclosure notification Source: BSE (29.09.2023) |
| Sopharma Buildings REIT-Sofia (SFB)
Sopharma Buildings REIT-Sofia presented a quarterly report for the Third Quarter of 2023. Source: BSE (31.10.2023) |
| At a meeting held by the Committee on Indices at BSE AD, according to Protocol No. 10 of 04.12.2023, the following decisions were taken:
III. In connection with item 8 of Appendix No. 3 (Calculation Methodology of BG REIT) to the Rules for Calculation of Indices of the Bulgarian Stock Exchange, the Commission on Indices determines the following free-float coefficients of the issues included in the base of BG REIT, which will enter into force as of 18.12.2023:
Stock code Issuer Free-float coefficient
ATER Advance Terafund REIT-Sofia 0.6106
BSP Balkan & Sea Properties REIT-Varna 0.3958
RPF Roy Property Fund REIT-Sofia 0.4467
SFB Sopharma Buildings REIT-Sofia 0.2723
SBPF Super Borovets Property Fund REIT-Burgas 0.6570
BREF Real Estate Fund Bulgaria REIT-Sofia 0.7429
CCBR CCB Real Estate Fund REIT-Sofia 0.5094
The free-float data of BG REIT's issues is a median value for the period from 02.09.2023 to 01.12.2023.
IV. In relation to item 15 of the Rules for calculating the index of companies with good corporate governance CGIX, the Indices Commission determines the following free-float coefficients of the issues included in the CGIX base, which will come into force as of 18.12.2023 year:
Stock code Issuer Free-float coefficient
ALB Albena AD-k.c. Albena 0.2993
BSE Bulgarian Stock Exchange AD-Sofia 0.4995
IHB Industrial Holding Bulgaria AD-Sofia 0.2195
KBG Corrado-Bulgaria AD-Strazitsa 0.1785
MONB Monbat AD-Sofia 0.1732
SFA Sopharma AD-Sofia 0.2910
CHIM Chemimport AD-Sofia 0.2149
Data on free-float issues from CGIX are as of 01.12.2023.
V. In relation to item 20 of the Rules for calculating an index of companies on the beam (beamX) market, the Commission on Indices determines the following free-float coefficients for the issues included in the beamX base, which will come into force as of 18.12 .2023:
Stock code Issuer Free-float coefficient
AMON AmonRa Energy AD-Sofia 0.0379
BEE BEE Smart Technologies AD-Sofia 0.2594
BDT Biodit AD-Sofia 0.1741
DRON Dronamix Capital AD-Sofia 0.9135
HRC HR Capital AD-Sofia 0.1805
IMP Impuls I AD-Sofia 0.8472
MFG MFG Invest AD-Sofia 0.1107
SIN Sin Cars Industry AD-Sofia 0.1228
SO Smart Organic AD-Sofia 0.0365
WIN Webit Investment Network AD-Varna 0.8546
Free-float emission data from beamX is a median value for the period 09/02/2023 to 12/01/2023.
VI. The Commission on Indices will determine the weighting coefficients of the issues included in the bases of the BSE indices and the CGIX index, based on the respective "close" prices as of 15.12.2023.
VII. The next meeting of the Indices Commission, at which the free-float coefficients of the issues included in the BSE indices and in the CGIX index will be determined, will be held on 03/04/2024, and these coefficients will come into force as of 03/18 .2024 Source: BSE (05.12.2023) |
| At a meeting of the Board of Directors of the BSE AD under Protocol No. 4/18.01.2024, the following decision was taken:
In connection with submitted under Art. 43, para. 1 of Part III of the Rules for admission to trading of the BSE Rules of Procedure application for transfer of the issue of shares issued by Sopharma Buildings REIT, exchange code SFB, ISIN code BG1100084075, the Board of Directors of the Stock Exchange terminates the registration of the above issue on the Alternative Market BàSE , Segment for companies with a special investment purpose, starting from 22.01.2024 (Monday).
Pursuant to Art. 33, para. 8 of Part III Rules for admission to trading, admission to trading on the BSE Main Market, Segment for companies with a special investment purpose (segment MIC: ZBUL), the issue of shares issued by Sopharma Buildings REIT, stock exchange code SFB, ISIN code BG1100084075, considered from 22.01.2024 (Monday).
Pursuant to Art. 42, para. 1 of Part III of the Rules for admission to trading, puts under surveillance the issue of shares issued by Sopharma Buildings REIT starting from 22.01.2024 for a period of 6 (six) months. Source: BSE (19.01.2024) |
| The Board of Directors of the Bulgarian Stock Exchange (BSE) moved the shares of Sopharma Buildings REIT and Lavena AD from the alternative market to the main market, "Standard" segment. The decision enters into force on January 22, 2024. "Sopharma Buildings" REIT became part of the index of companies with a special investment purpose BGREIT in September 2023. The company increased its capital, acquired the grounds of the former base of "Unipharm" in the quarter " Darvenica" in Sofia and a residential complex is currently being built on the site of the old buildings. In the last year, the shares of Sopharma Buildings increased in price by over 477%, and the market capitalization of the company reached almost BGN 59.3 million. In the last year, the shares of "Lavena" became cheaper by nearly 37%, and the market capitalization is almost BGN 17.4 million. Source: investor.bg (19.01.2024) |
| Sopharma Buildings REIT (SFB)
Notification of the decision of the BSE Board of Directors for a transfer of the issue of shares from the BaSE Alternative Market to the BSE Main Market, Special Purpose Vehicles Segment (segment MIC: ZBUL) as of 22 January 2024 (Monday) Source: BSE (22.01.2024) |
| Sopharma Buildings REIT (SFB)
Notification of obtained construction permit Source: BSE (24.01.2024) |
| At a meeting of the Board of Directors of the BSE AD under Protocol No. 13 dated 07.03.2024, the following decisions were taken:
II. Revision based on BGBX 40
Pursuant to Art. 15, item 4 of the BSE Index Calculation Rules in connection with item 15 of Appendix No. 2 (Methodology for BGBX 40 calculation), the Board of Directors excludes the following seven share issues from the BGBX 40 index base:
BPF Bravo Property Fund REIT-Sofia;
HIKA Industrial Capital Holding AD-Sofia;
HNVK Holding Nov Vek AD;
HRZ Rodna Zemya Holding AD-Sofia;
IHB Industrial Holding Bulgaria AD-Sofia;
SPDY Speedy AD-Sofia; and
T57 Trace Group Hold AD-Sofia;
and adds the following seven share issues to the base of the BGBX 40 index:
PET Petrol AD;
SFB Sopharma Buildings REIT;
HLEV Golden Lev Holding AD;
BNR Bianor Holding AD-Sofia;
BBRD Billboard AD-Sofia;
BSP Balkan and Sea Properties REIT-Varna; and
TXIM TB Texim Bank AD-Sofia.
III. Basis Revision of BG REIT
Pursuant to Art. 15, item 4 of the BSE Index Calculation Rules in connection with item 12 of Appendix No. 3 (Calculation Methodology of BG REIT), the Board of Directors does not make changes to the base of the BG REIT index.
IV. Revision based on BG TR30
Pursuant to Art. 15, item 4 of the Rules for calculating BSE indices in connection with item 17 of Appendix No. 4 (Methodology for calculating BG TR30), the Board of Directors excludes the following five issues of shares from the basis of the BG TR30 index:
HNVK Holding Nov Vek AD,
HSI Sila Holding AD,
HSOF Holding Sveta Sofia AD-Sofia,
NEOH Neohim AD-Dimitrovgrad, i
TBS Telelink Business Services Group AD-Sofia;
and adds the following five share issues to the base of the BG TR30 index:
FIB TB First Investment Bank AD-Sofia,
TXIM TB Texim Bank AD-Sofia,
SFB Sopharma Buildings REIT,
CCB TB Central Cooperative Bank AD, i
HLEV Golden Lev Holding AD
V. Revision based on the beamX index
Pursuant to Art. 15, item 4 of the Rules for calculating BSE indices in connection with item 20 of the Rules for calculating the index of companies on the beam (beamX) market, the Board of Directors excludes the following issue of shares from the base of the beamX index:
BEE BEE Smart Technologies AD-Sofia;
and adds the following issue of shares to the base of the beamX index:
ITF ITF Group AD-Sofia.
Decisions to change the base of the BGBX 40, BG REIT, BG TR30 and beamX indices will come into force as of March 18, 2024. Source: BSE (08.03.2024) |
| The following decisions were taken at a meeting of the Indices Commission of BSE AD under Protocol No. 2 dated 07.03.2024:
III. In connection with item 8 of Appendix No. 3 (Calculation Methodology of BG REIT) to the Rules for Calculation of Indices of the Bulgarian Stock Exchange, the Commission on Indices determines the following free-float coefficients of the issues included in the base of BG REIT, which will enter into force as of 18.03.2024:
Stock code Issuer Free-float coefficient
ATER Advance Terafund REIT-Sofia 0.6104
BSP Balkan & Sea Properties REIT-Varna 0.3952
RPF Roy Property Fund REIT-Sofia 0.3915
SFB Sopharma Buildings REIT 0.2713
SBPF Super Borovets Property Fund REIT-Burgas 0.6571
BREF Real Estate Fund Bulgaria REIT-Sofia 0.7428
CCBR CCB Real Estate Fund REIT-Sofia 0.5094
The free-float data of BG REIT's issues is a median value for the period from 02.12.2023 to 01.03.2024.
IV. In connection with item 22 of the Rules for calculating an index of companies on the beam (beamX) market, the Commission on Indices determines the following free-float coefficients for the issues included in the beamX base, which will come into force as of 18.03.2024 year:
Stock code Issuer Free-float coefficient
ITF ITF Group AD-Sofia 0.1148
AMON AmonRa Energy AD-Sofia 0.0242
BDT Biodit AD-Sofia 0.1726
DRON Dronamix Capital AD-Sofia 0.9193
HRC HR Capital AD-Sofia 0.1805
IMP Impuls Growth AD 0.8399
MFG MFG Invest AD-Sofia 0.1107
SIN Sin Cars Industry AD-Sofia 0.1228
SO Smart Organic AD-Sofia 0.0365
WIN Webit Investment Network AD-Varna 0.8546
Free-float emission data from beamX is a median value for the period 02/12/2023 to 01/03/2024.
V. The Commission on Indices will determine the weighting coefficients of the issues included in the BSE index bases (including in the index of companies on the beam market) based on the relevant "closing" prices as of 03/15/2024.
VI. The next meeting of the Indices Commission, at which the free-float coefficients of the issues included in the BSE indices (including the index of companies on the BEAM market) will be determined, will be held on 03.06.2024, as these coefficients will come into force starting from 24.06.2024. Source: BSE (08.03.2024) |
| BSE Indices Committee adopted the following decisions under Record of Proceedings No. 3 at its session held on 17 March 2024:
I. With reference to item 14 of Appendix No. 1 (SOFIX Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following weight factors, other than one (1), of the SOFIX constituents, in effect from 18 March 2024:
BSE code Issuer Weight factor
SFA Sopharma AD-Sofia 0.641847
SLYG Shelly Group AD 0.510679
II. With reference to item 12 of Appendix No. 2 (BGBX 40 Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following weight factors, other than one (1), of the BGBX 40 constituents, in effect from 18 March 2024:
BSE code Issuer Weight factor
SFA Sopharma AD-Sofia 0.694499
SLYG Shelly Group AD 0.552572
III. With reference to item 9 of Appendix No. 3 (BG REIT Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following weight factors, other than one (1), of the BG REIT constituents, in effect from 18 March 2024:
BSE code Issuer Weight factor
ATER Advance Terrafund REIT-Sofia 0.315831
BSP Balkan and Sea Properties REIT-Varna 0.868002
BREF Bulgarian Real Estate Fund REIT-Sofia 0.816672
IV. With reference to item 15 of Appendix No. 4 (BG TR30 Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following weight factors of the BG TR30 constituents, in effect from 18 March 2024:
BSE code Issuer Weight factor
AGH Agria Group Holding AD-Varna 1.375131
ATER Advance Terrafund REIT-Sofia 8.114515
BSP Balkan and Sea Properties REIT-Varna 1.174841
BSE Bulgarian Stock Exchange-Sofia 1.801422
VAM Velgraf Asset Management AD-Sofia 5.773789
GR6 Gradus AD-Stara Zagora 18.014222
DUH Doverie United Holding PLC 2.962865
EUBG Eurohold Bulgaria AD 21.110417
EAC Elana Agrocredit AD-Sofia 25.019753
HLEV Zlaten Lev Holding AD 7.720381
11C Eleven Capital AD-Sofia 1.598895
GTH Galata Investment Company AD-Varna 10.235354
CAPM Capital Management SPV-Sofia 0.346427
MSH M+S Hydraulic AD-Kazanlak 2.456485
HRZ Rodna Zemya Holding AD-Sofia 8.947461
SYN Synthetica AD-Sofia 0.495804
SGH Sirma Group Holding AD-Sofia 38.058216
SFA Sopharma AD-Sofia 4.275527
SFB Sopharma Buildings REIT 1.732137
SFT Sopharma Trading AD-Sofia 4.699362
SPH Stara Planina Hold AD-Sofia 2.549182
SBPF Super Borovetz Property Fund REIT-Burgas 9.317701
FIB CB First Investment Bank AD-Sofia 10.555208
TXIM CB Texim Bank AD-Sofia 7.720381
CCB CB Central Cooperative Bank AD 17.894923
BREF Bulgarian Real Estate Fund REIT-Sofia 10.392821
CHIM Chimimport AD-Sofia 38.491928
CHSB Himsnab Bulgaria AD-Sofia 0.442973
HVAR Holding Varna AD 0.600474
SLYG Shelly Group AD 0.391614
V. With reference to item 24 of the Rules for Calculating the BEAM Market Companies' Index (beamX), the Indices Committee adopted the following weight factors, other than one (1), of the beamX constituents, in effect from 18 March 2024:
BSE code Issuer Weight factor
DRON Dronamics Capital AD-Sofia 0.688518 Source: BSE (19.03.2024) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT publishes the Annual Financial Report for the activities of companies with a special investment purpose - ESEF format as of 12-31-2023. Source: BSE (28.03.2024) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented a quarterly report for the First Quarter of 2024. Source: BSE (29.04.2024) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT convenes a regular AGM on 20.06.2024 at 2:00 p.m. in the city of Sofia, 5 Lachezar Stanchev St., Sopharma Business Towers, Building A, floor 20, with the following agenda:
- Report of the management bodies on the company's activities in 2023;
- Adoption of the company's annual financial report for 2023;
- Report of the registered auditor for 2023;
- Report of the Audit Committee for 2023;
- Report of the Director of Investor Relations for 2023;
- Acceptance of a report on the implementation of the Policy on the remuneration of the members of the governing bodies;
- Exemption of the members of the governing bodies from responsibility for their activities in 2023;
- Election of a registered auditor for 2024;
- Decision on distribution of financial result. Draft decision: Do not distribute a dividend for 2023, as the company ended up with a loss in the amount of BGN 143,882.22, and after its conversion in accordance with Art. 29, para. 3 of the ZDSITSDS - loss in the amount of BGN 174,052.17. The formed loss for 2023, in the amount of BGN 143,882.22, to be covered by the accumulated reserves from the Reserve fund.
- Changes in the remuneration of the members of the Audit Committee;
- Determining the amount of remuneration of the members of the governing bodies.
- Revision of the remuneration policy for the members of the governing bodies.
- In the absence of a quorum, the meeting will be held on 07/05/2024 at 14:00 at the same place and with the same agenda.
The right to vote in the General Meeting of Shareholders is exercised by the persons registered as such with the right to vote in the central register of securities 14 days before the date of the General Meeting of Shareholders, or as of 06.06.2024.
The last date for concluding transactions with shares of this company on the Stock Exchange, as a result of which the acquirer will be able to exercise the right to vote in the General Meeting of Shareholders, is 06.04.2024. Source: BSE (21.05.2024) |
| The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 8 at its session held on 03 June 2024:
III. With reference to item 8 of Appendix No. 3 (BG REIT Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BG REIT in effect from 24 June 2024:
BSE code Issuer Free-float factor
ATER Advance Terrafund REIT-Sofia 0.6104
BSP Balkan and Sea Properties REIT 0.4111
RPF Roi Property Fund REIT 0.4097
SFB Sopharma Buildings REIT 0.2691
SBPF Super Borovetz Property Fund REIT 0.6070
BREF Bulgarian Real Estate Fund REIT-Sofia 0.7428
CCBR CCB Real Estate Fund REIT-Sofia 0.5094
The free-float data on the issues of BG REIT presented herein are the median values for the period 02 March - 01 June 2024.
IV. With reference to item 22 of the Rules for Calculating the BEAM Market Companies' Index (beamX), the Indices Committee adopted the following free-float factors of the issues comprising beamX in effect from 24 June 2024:
BSE code Issuer Free-float factor
ITF ITF Group AD-Sofia 0.1148
AMON AmonRa Energy AD 0.0242
BDT Biodit AD 0.1719
DRON Dronamics Capital AD 0.9244
HRC HR Capital JSC-Sofia 0.1805
IMP ImPulse Growth AD 0.834
IPSP IpoTech Sofcom AD 0.6219
MFG MFG Invest AD 0.1107
SIN Sin Cars Industry AD-Sofia 0.1228
WIN Webit Investment Network AD 0.8546
The free-float data on the issues of beamX presented herein are the median values for the period 02 March - 01 June 2024.
V. The Indices Committee will define the weight factors of the issues comprising the BSE Indices (including beamX) based on the closing prices on 21 June 2024.
VI. The next session of the Indices Committee, at which free-float factors are to be specified, shall be held on 02 September 2024, where these are to enter into force as of 24 September 2024. Source: BSE (04.06.2024) |
| The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 8 at its session held on 03 June 2024:
I. With reference to item 12 of Appendix No. 1 (SOFIX Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising SOFIX in effect from 24 June 2024:
BSE code Issuer Free-float factor
AGH Agria Group Holding AD 0.2135
ATER Advance Terrafund REIT-Sofia 0.6104
BSE Bulgarian Stock Exchange AD 0.4995
DUH Doverie United Holding PLC 0.5954
EUBG Eurohold Bulgaria AD 0.4615
EAC Elana Agrocredit AD 0.6626
MSH M+S Hydraulic AD-Kazanlak 0.2295
SGH Sirma Group Holding AD 0.5988
SFA Sopharma AD 0.2785
FIB CB First Investment Bank AD 0.1107
CCB CB Central Cooperative Bank AD 0.1666
BREF Bulgarian Real Estate Fund REIT 0.7428
CHIM Chimimport AD 0.2154
HVAR Holding Varna AD 0.3191
SLYG Shelly Group AD 0.3104
The free-float data on the issues of SOFIX presented herein are the median values for the period 02 March - 01 June 2024.
II. With reference to item 11 of Appendix No. 2 (BGBX 40 Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BGBX 40 in effect from 24 June 2024:
BSE code Issuer Free-float factor
AGH Agria Group Holding AD 0.2135
ATER Advance Terrafund REIT-Sofia 0.6104
ALB Albena AD 0.2993
ALCM Alcomet AD-Shumen 0.0990
BNR Bianor Holding AD 0.3225
BBRD Billboard AD-Sofia 0.3544
BSP Balkan and Sea Properties REIT 0.4111
BSE Bulgarian Stock Exchange AD 0.4995
VAM Velgraf Asset Management AD-Sofia 0.3845
GR6 Gradus AD-Stara Zagora 0.1788
DUH Doverie United Holding PLC 0.5954
EUBG Eurohold Bulgaria AD 0.4615
EAC Elana Agrocredit AD 0.6626
EMKA EMKA AD-Sevlievo 0.2268
HLEV Zlaten Lev Holding AD 0.3539
ZHBG Zarneni Hrani Bulgaria AD-Sofia 0.2001
11C Eleven Capital AD-Sofia 0.5466
GTH Galata Investment Company AD 0.5394
KBG Korado Bulgaria AD 0.1785
MSH M+S Hydraulic AD-Kazanlak 0.2295
MONB Monbat AD 0.1732
NEOH Neochim AD 0.3139
PET Petrol AD 0.0570
SNRG Synergon Holding AD-Sofia 0.4322
SGH Sirma Group Holding AD 0.5988
SFA Sopharma AD 0.2785
SFB Sopharma Buildings REIT 0.2691
SFT Sopharma Trading AD-Sofia 0.1232
SCOM Sofia Commerce-Pawn Brokerage AD 0.3504
SPH Stara Planina Hold AD-Sofia 0.5935
FIB CB First Investment Bank AD 0.1107
TXIM CB Texim Bank AD-Sofia 0.4255
CCB CB Central Cooperative Bank AD 0.1666
TBS Telelink Business Services Group AD 0.1304
TIB Telematic Interactive Bulgaria AD-Sofia 0.0746
BREF Bulgarian Real Estate Fund REIT-Sofia 0.7428
HES Hydraulic Elements and Systems /HES/ AD-Yambol 0.2029
CHIM Chimimport AD 0.2154
HVAR Holding Varna AD 0.3191
SLYG Shelly Group AD 0.3104
The free-float data on the issues of BGBX 40 presented herein are the median values for the period 02 March - 01 June 2024. Source: BSE (04.06.2024) |
| The following decisions were taken at a meeting of the Committee on Indices at BSE AD under Protocol No. 9 of 22.06.2024:
I. In relation to item 14 of Appendix No. 1 (Methodology for calculating SOFIX) to the Rules for calculating indices of the Bulgarian Stock Exchange, the Indices Commission determines the following weighting coefficients, other than 1 (one), of issues from the SOFIX base , which will enter into force as of 24.06.2024:
Stock code Issuer Weighting factor
SFA Sopharma AD 0.716021
SLYG Shelley Group AD 0.552430
II. In connection with item 14 of Appendix No. 2 (Methodology for calculating BGBX 40) to the Rules for calculating indices of the Bulgarian Stock Exchange, the Indices Commission determines the following weighting coefficients, other than 1 (one), of issues based on BGBX 40 , which will enter into force as of 24.06.2024:
Stock code Issuer Weighting factor
SFA Sopharma AD 0.756685
SLYG Shelly Group AD 0.583803
III. In connection with item 9 of Appendix No. 3 (Methodology for calculation of BG REIT) to the Rules for calculation of indices of the Bulgarian Stock Exchange, the Commission on Indices determines the following weighting coefficients, other than 1 (one), of issues from the base of BG REIT , which will enter into force as of 24.06.2024:
Stock code Issuer Weighting factor
ATER Advance Terafund REIT 0.325203
BSP Balkan & Sea Properties REIT 0.820488
BREF Real Estate Fund Bulgaria REIT 0.835147
IV. In connection with item 15 of Appendix No. 4 (Methodology for calculating BG TR30) to the Rules for calculating indices of the Bulgarian Stock Exchange, the Indices Commission determines the following weighting factors of the emissions from the BG TR30 base, which will come into force, from 24.06.2024:
Stock code Issuer Weighting factor
AGH Agria Group Holding AD 1.363718
ATER Advance Terafund REIT-Sofia 8.919916
BSP Balkan and Sea Properties REIT 1.233275
BSE Bulgarian Stock Exchange AD 1.916577
VAM Velgraf Asset Management AD-Sofia 6.009605
GR6 Gradus AD-Stara Zagora 19.037136
DUH Doverie United Holding AD 3.208748
EUBG Eurohold Bulgaria AD 18.300215
EAC Elana Agrocredit AD 25.786667
HLEV Zlaten Lev Holding AD 7.879259
11C Eleven Capital AD-Sofia 1.620876
GTH Investment Company Galata AD 11.167454
CAPM Capital Management REIT-Sofia 0.354567
MSH M+C hydraulic AD-Kazanlak 2.836533
HRZ Rodna Zemya Holding AD 9.392494
SYN Synthetika AD 0.480768
SGH Sirma Group Holding AD 28.507873
SFA Sopharma AD 4.743367
SFB Sopharma Buildings REIT 2.040671
SFT Sopharma Trading AD-Sofia 4.848775
SPH Stara planina hold AD-Sofia 2.812849
SBPF Super Borovets Property Fund REIT 9.330702
FIB TB First Investment Bank AD-Sofia 6.446667
TXIM TB Texim Bank AD-Sofia 7.879259
CCB TB Central Cooperative Bank AD 17.728333
BREF Real Estate Fund Bulgaria REIT-Sofia 11.346133
CHIM Chimimport AD 40.521905
CHSB Himsnab Bulgaria AD-Sofia 0.453845
HVAR Holding Varna AD 0.627552
SLYG Shelley Group AD 0.411092
V. In relation to item 24 of the Rules for calculating an index of companies on the beam (beamX) market, the Commission on Indices determines the following weighting coefficients, other than 1 (one), of emissions based on beamX, which will come into force, as of 24.06.2024:
Stock code Issuer Weighting factor
DRON Dronamix Capital AD 0.597380
IMP Impulse Growth AD 0.955400 Source: BSE (25.06.2024) |
| Sopharma Buildings REIT (SFB)
At the regular General Meeting of Shareholders of Sopharma Buildings REIT held on 20.06.2024, the following decisions were taken:
- Accepts the report of the management bodies on the company's activities in 2023;
- Accepts the company's annual financial report for 2023;
- Accepts the report of the registered auditor for 2023;
- Accepts the report of the Audit Committee for 2023;
- Adopts the report of the Investor Relations Director for 2023;
- Accepts the report on the implementation of the Policy on the remuneration of the members of the governing bodies;
- Releases the members of the governing bodies from responsibility for their activities in 2023;
- Elects a registered auditor for 2024;
- Decision on distribution of financial result: No dividend is distributed for 2023, as the company ended up with a loss in the amount of BGN 143,882.22, and after its conversion in accordance with Art. 29, para. 3 of the Tax and Social Insurance Agency - loss in the amount of BGN 174,052.17. The formed loss for 2023, in the amount of BGN 143,882.22, will be covered by the accumulated reserves from the Reserve fund.
- Determines the amount of remuneration for the members of the Audit Committee;
- Determines the amount of remuneration of the members of the governing bodies.
- It does not change the remuneration policy for the members of the management bodies. Source: BSE (25.06.2024) |
| Sopharma Buildings REIT (SFB)
In view of the expiry of the surveillance period, BSE terminates the surveillance and confirms the listing on the BSE Main Market, Special Purpose Vehicles Segment, of the issue of shares of Sopharma Buildings REIT (SFB), ISIN BG1100084075. Source: BSE (26.07.2024) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented a quarterly report for the Second Quarter of 2024. Source: BSE (31.07.2024) |
| The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 11 at its session held on 09 September 2024:
III. With reference to item 8 of Appendix No. 3 (BG REIT Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BG REIT in effect from 24 September 2024:
BSE code Issuer Free-float factor
ATER Advance Terrafund REIT-Sofia 0.6103
BSP Balkan and Sea Properties REIT 0.4114
RPF Roi Property Fund REIT 0.4092
SFB Sopharma Buildings REIT 0.2691
SBPF Super Borovetz Property Fund REIT 0.6066
BREF Bulgarian Real Estate Fund REIT-Sofia 0.7428
CCBR CCB Real Estate Fund REIT-Sofia 0.5094
The free-float data on the issues of BG REIT presented herein are the median values for the period 02 June 2024 - 01 September 2024.
IV. With reference to item 22 of the Rules for Calculating the BEAM Market Companies' Index (beamX), the Indices Committee adopted the following free-float factors of the issues comprising beamX in effect from 24 September 2024:
BSE code Issuer Free-float factor
ITF ITF Group AD 0.1148
BEE Bee Smart Technologies AD-Sofia 0.2593
BDT Biodit AD 0.1719
DRON Dronamics Capital AD 0.9278
HRC HR Capital JSC-Sofia 0.1805
IMP ImPulse Growth AD 0.8500
IPSP IpoTech Sofcom AD 0.5636
MFG MFG Invest AD 0.1107
SIN Sin Cars Industry AD-Sofia 0.1228
WIN Webit Investment Network AD-Varna 0.8546
The free-float data on the issues of beamX presented herein are the median values for the period 02 June 2024 - 01 September 2024.
V. The Indices Committee will define the weight factors of the issues comprising the BSE Indices (including beamX) based on the closing prices on 20 September 2024.
VI. The next session of the Indices Committee, at which free-float factors are to be specified, shall be held on 02 December 2024, where these are to enter into force as of 23 December 2024. Source: BSE (10.09.2024) |
| The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 11 at its session held on 09 September 2024:
I. With reference to item 12 of Appendix No. 1 (SOFIX Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising SOFIX in effect from 24 September 2024:
BSE code Issuer Free-float factor
AGH Agria Group Holding AD 0.2135
ATER Advance Terrafund REIT-Sofia 0.6103
BSE Bulgarian Stock Exchange AD 0.4995
DUH Doverie United Holding PLC 0.6002
EUBG Eurohold Bulgaria AD 0.5004
EAC Elana Agrocredit AD 0.6650
SGH Sirma Group Holding AD 0.5988
SFA Sopharma AD 0.2743
SFT Sopharma Trading AD-Sofia 0.1202
FIB CB First Investment Bank AD-Sofia 0.1107
CCB CB Central Cooperative Bank AD 0.1666
BREF Bulgarian Real Estate Fund REIT-Sofia 0.7428
CHIM Chimimport AD 0.2154
HVAR Holding Varna AD 0.3188
SLYG Shelly Group AD 0.3044
The free-float data on the issues of SOFIX presented herein are the median values for the period 02 June 2024 - 01 September 2024.
II. With reference to item 11 of Appendix No. 2 (BGBX 40 Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BGBX 40 in effect from 24 September 2024:
BSE code Issuer Free-float factor
AGH Agria Group Holding AD 0.2135
ATER Advance Terrafund REIT-Sofia 0.6103
ALB Albena AD 0.2993
ALCM Alcomet AD-Shumen 0.0990
BNR Bianor Holding AD 0.3285
BSE Bulgarian Stock Exchange AD 0.4995
VAM Velgraf Asset Management AD-Sofia 0.3846
GR6 Gradus AD-Stara Zagora 0.1788
DUH Doverie United Holding PLC 0.6002
EUBG Eurohold Bulgaria AD 0.5004
EAC Elana Agrocredit AD 0.6650
EMKA EMKA AD-Sevlievo 0.2268
ZHBG Zarneni Hrani Bulgaria AD-Sofia 0.2001
11C Eleven Capital AD-Sofia 0.5466
GTH Galata Investment Company AD 0.5393
IHB Industrial Holding Bulgaria PLC-Sofia 0.2177
KBG Korado Bulgaria AD 0.1785
MSH M+S Hydraulic AD-Kazanlak 0.2295
MONB Monbat AD 0.1725
NEOH Neochim AD 0.3139
PET Petrol AD 0.0570
SNRG Synergon Holding AD-Sofia 0.4322
SGH Sirma Group Holding AD 0.5988
SO Smart Organic AD 0.1485
SFA Sopharma AD 0.2743
SFB Sopharma Buildings REIT 0.2691
SFT Sopharma Trading AD-Sofia 0.1202
SCOM Sofia Commerce-Pawn Brokerage AD 0.3504
SPDY Speedy AD-Sofia 0.1010
SPH Stara Planina Hold AD-Sofia 0.5935
FIB CB First Investment Bank AD-Sofia 0.1107
CCB CB Central Cooperative Bank AD 0.1666
TBS Telelink Business Services Group AD 0.1304
TIB Telematic Interactive Bulgaria AD-Sofia 0.0746
T57 Trace Group Hold AD-Sofia 0.1877
BREF Bulgarian Real Estate Fund REIT-Sofia 0.7428
HES Hydraulic Elements and Systems /HES/ AD-Yambol 0.2029
CHIM Chimimport AD 0.2154
HVAR Holding Varna AD 0.3188
SLYG Shelly Group AD 0.3044
The free-float data on the issues of BGBX 40 presented herein are the median values for the period 02 June 2024 - 01 September 2024. Source: BSE (10.09.2024) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented a quarterly report for the Third Quarter of 2024. Source: BSE (31.10.2024) |
| At a meeting of the Committee on Indices at the BSE AD under Protocol No. 13 of 02.12.2024, the following decisions were taken:
III. In connection with item 8 of Appendix No. 3 (Calculation Methodology of BG REIT) to the Rules for Calculation of Indices of the Bulgarian Stock Exchange, the Indices Commission determines the following coefficients for free-float of the issues included in the base of BG REIT, which will come into force, as of 23.12.2024:
Stock code Issuer Free-float coefficient
ATER Advance Terrafund REIT 0.6102
BSP Balkan & Sea Properties REIT 0.4113
RPF Roy Property Fund REIT 0.4084
SFB Sopharma Buildings REIT 0.2695
SBPF Super Borovets property fund REIT 0.6071
BREF Real Estate Fund Bulgaria REIT 0.7428
CCBR CCB Real Estate Fund REIT 0.5092
The free-float data of BG REIT's issues is a median value for the period from 02.09.2024 to 01.12.2024.
IV. In connection with item 22 of the Rules for calculating an index of companies on the beam (beamX) market, the Commission on Indices determines the following free-float coefficients of the issues included in the beamX base, which will come into force starting from 23.12.2024:
Stock code Issuer Free-float coefficient
ITF ITF Group AD 0.1148
BEE Smart Technologies AD 0.2593
BDT Biodit AD 0.1719
DRON Dronamix Capital AD 0.9372
HRC Capital AD 0.1805
IMP Impulse growth AD 0.8515
IPSP IpoTech Sofcom AD 0.6219
MFG MFG Invest AD 0.1107
SIN Sin Kars Industries AD 0.1228
WIN Webit Investment Network AD 0.8546
Free-float emission data from beamX is a median value for the period 09/02/2024 to 12/01/2024.
V. The Commission on Indices will determine the weighting coefficients of the issues included in the BSE index bases (including in the index of companies on the beam market) based on the relevant "closing" prices as of 12/20/2024.
VI. The next meeting of the Commission on Indices, at which the free-float coefficients of the issues included in the indices of the BSE (including the index of companies on the BEAM market) will be determined, will be held on 03.04.2025, as these coefficients will come into force starting from 24.03.2025. Source: BSE (03.12.2024) |
| At a meeting of the Committee on Indices at the BSE AD under Protocol No. 13 of 02.12.2024, the following decisions were made:
I. In connection with item 12 of Appendix No. 1 (Methodology for calculating SOFIX) to the Rules for calculating indices of the Bulgarian Stock Exchange, the Indices Commission determines the following free-float coefficients for the issues included in the SOFIX base, which will come into force as of 23.12.2024:
Stock code Issuer Free-float coefficient
AGH Agria Group Holding AD 0.2135
ATER Advance Terrafund REIT 0.6102
BSE Bulgarian Stock Exchange AD 0.4995
DUH Trust United Holding AD 0.6016
EUBG Eurohold Bulgaria AD 0.4956
EAC Elana Agrocredit AD 0.6650
SGH Sirma Group Holding AD 0.5988
SFA Sopharma AD 0.2730
SFT Sopharma Trading AD 0.1196
FIB TB First Investment Bank AD 0.1107
CCB TB Central Cooperative Bank AD 0.1666
BREF Real Estate Fund Bulgaria REIT 0.7428
CHIM Chimimport AD 0.2159
HVAR Holding Varna AD 0.3184
SLYG Shelley Group AD 0.3048
Free-float emissions data from SOFIX is a median value for the period from 09/02/2024 to 12/01/2024.
II. In connection with item 11 of Appendix No. 2 (Methodology for calculating BGBX40) to the Rules for calculating indices of the Bulgarian Stock Exchange, the Indices Commission determines the following coefficients for free-float of the issues included in the base of BGBX 40, which will enter into force, from 23.12.2024:
Stock code Issuer Free-float coefficient
AGH Agria Group Holding AD 0.2135
ATER Advance Terrafund REIT 0.6102
ALB Albena AD 0.2993
ALCM Alcomet AD 0.0990
BNR Bianor Holding AD 0.3285
BSE Bulgarian Stock Exchange AD 0.4995
VAM Velgraf Asset Management AD 0.3835
GR6 Grade AD 0.1788
DUH Trust United Holding AD 0.6016
EUBG Eurohold Bulgaria AD 0.4956
EAC Elana Agrocredit AD 0.6650
EMKA AD 0.2268
ZHBG Cereals Bulgaria AD 0.2001
11C Eleven Capital AD 0.5466
GTH Investment Company Galata AD 0.5369
IHB Industrial Holding Bulgaria AD 0.2174
KBG Corrado-Bulgaria AD 0.1785
MSH M+C hydraulic AD 0.2295
MONB Monbat AD 0.1724
NEOH Neohim AD 0.3139
PET Petrol AD ??0.0570
SNRG Synergon Holding AD 0.4204
SGH Sirma Group Holding AD 0.5988
SO Smart organic AD 0.1485
SFA Sopharma AD 0.2730
SFB Sopharma Buildings REIT 0.2695
SFT Sopharma Trading AD 0.1196
SCOM Sofia commerce-pawn houses AD 0.3381
SPDY Speedy AD 0.1010
SPH Stara Planina Hold AD 0.5935
FIB TB First Investment Bank AD 0.1107
CCB TB Central Cooperative Bank AD 0.1666
TBS Telelink Business Services Group AD 0.1304
TIB Telematic Interactive Bulgaria AD 0.0756
T57 Trace Group Hold AD 0.1877
BREF Real Estate Fund Bulgaria REIT 0.7428
HES Hydraulic elements and systems /HES/ AD 0.2029
CHIM Chimimport AD 0.2159
HVAR Holding Varna AD 0.3184
SLYG Shelley Group AD 0.3048
Free-float emission data from BGBX40 is a median value for the period from 09/02/2024 to 12/01/2024. Source: BSE (03.12.2024) |
| "Sopharma Buildings" REIT concluded with "DSK Bank" AD a standard investment loan agreement in the amount of BGN 10,000,000, intended for partial financing, excluding VAT, of expenses related to the acquisition of a land plot in Sofia, 3 Kliment Ohridski Blvd. The money will be used to finance up to 100% of the expenses, excluding VAT, for the acquisition through construction and commissioning of "Residential buildings with shops, a kindergarten, underground garages and above-ground parking spaces - Stage I", on the same land plot. The investment loan will bear annual interest on regular principal, formed by a variable reference interest rate, representing a weighted average deposit index (WDI) plus an agreed premium of 4.9 percent. The loan has a maturity date of December 4, 2025, the principal grace period is until December 3, 2027, and the repayment deadline is December 4, 2027. The value of the weighted average deposit index for the month of December is 0.3 percent. "Sopharma Buildings" is a joint-stock company with a special investment purpose, investing in real estate. The largest shareholders in the company are "Sopharma" AD with a share of 31.47%, "Telekomplekt Invest" AD - 9.88%, Ognyan Donev - 11.91% and Ventsislav Stoev - 19.62 percent. "Sopharma Buildings" did not distribute a dividend for 2023, as the company ended last year with a loss of BGN 143,882. Source: Banker (05.12.2024) |
| Sopharma Buildings REIT (SFB)
On 04.12.2024, Sopharma Buildings REIT concluded a standard investment loan agreement with DSK Bank AD in the amount of BGN 10,000,000. Source: BSE (05.12.2024) |
| Sopharma Buildings REIT (SFB)
The Financial Supervision Commission approved on 10 December 2024 the replacement of CB United Bulgarian Bank with CB DSK Bank as a depositary bank of Sopharma Buildings REIT. Source: BSE (11.12.2024) |
| Sopharma Buildings REIT (SFB)
In connection with a decision to replace CB United Bulgarian Bank with CB DSK Bank as a depositary bank, Sopharma Buildings REIT notifies of the transfer of all assets to the new depositary bank. Source: BSE (16.12.2024) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for the Fourth Quarter of 2024. Source: BSE (31.01.2025) |
| Sopharma AD reports a decline in unconsolidated profit by BGN 17.5 million, or nearly a third, to BGN 30.1 million for 2024. Sales decrease by BGN 21 million, or 7%, to BGN 265.5 million. Sales of products are down by 6.5% to BGN 235 million. The main foreign markets are Russia, Ukraine, Belarus, Poland, the countries of the former Yugoslavia, Georgia, Armenia, Kazakhstan. Bulgaria has a share of about one third. The consolidated report is important for Sopharma, as in the absence of progress in the production of medicines, the company has found other niches. The subsidiary Sopharma Trading has over BGN 1 billion. turnover from drug sales, the subsidiary "Sopharma Imoti" REIT (in which "Sopharma" has a 46% share) rents out office space, the subsidiary "Sopharma Buildings" REIT is building buildings in Sofia (on the site of the former "Unipharm" in the Darvenitsa district), and "Dover United Holding" AD (23% share of "Sopharma") has a bank in Moldova and holds the franchise of "Monsieur Bricolage" for Bulgaria. Source: investor.bg (03.02.2025) |
| The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 2 at its session held on 10 March 2025:
I. With reference to item 12 of Appendix No. 1 (SOFIX Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising SOFIX in effect from 24 March 2025:
BSE code Issuer Free-float factor
ATER Advance Terrafund REIT 0.6100
BSE Bulgarian Stock Exchange AD 0.4995
DUH Doverie United Holding PLC 0.6018
EUBG Eurohold Bulgaria AD 0.4710
SGH Sirma Group Holding AD 0.5988
SO Smart Organic AD 0.1485
SFA Sopharma AD 0.2726
FIB CB First Investment Bank AD 0.1107
CCB CB Central Cooperative Bank AD 0.1666
TIB Telematic Interactive Bulgaria AD 0.0955
WISR Wiser Technology AD 0.4774
BREF Bulgarian Real Estate Fund REIT 0.7428
CHIM Chimimport AD 0.2159
HVAR Holding Varna AD 0.3183
SLYG Shelly Group SE 0.3036
The free-float data on the issues of SOFIX presented herein are the median values for the period 02 December 2024 - 01 March 2025.
II. With reference to item 11 of Appendix No. 2 (BGBX 40 Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BGBX 40 in effect from 24 March 2025:
BSE code Issuer Free-float factor
AGH Agria Group Holding AD 0.2119
ATER Advance Terrafund REIT 0.6100
ALB Albena AD 0.2993
BPF Bravo Property Fund REIT 0.1671
BMTL Bulmetal AD 0.2343
BSE Bulgarian Stock Exchange AD 0.4995
GR6 Gradus AD 0.1788
DUH Doverie United Holding PLC 0.6018
EUBG Eurohold Bulgaria AD 0.4710
EAC Elana Agrocredit AD 0.6650
EMKA EMKA AD 0.2268
ZHBG Zarneni Hrani Bulgaria AD 0.2001
11C Eleven Capital AD 0.5510
HIKA Industrial Capital Holding AD 0.5662
KBG Korado-Bulgaria AD 0.1785
MSH M+S Hydraulic AD 0.2295
MONB Monbat AD 0.1724
NEOH Neochim AD 0.3139
PET Petrol AD 0.0570
SNRG Synergon Holding AD 0.4204
SGH Sirma Group Holding AD 0.5988
SO Smart Organic AD 0.1485
SFA Sopharma AD 0.2726
SFB Sopharma Buildings REIT 0.2695
SFI Sopharma Properties REIT 0.0901
SFT Sopharma Trading AD 0.1201
SCOM Sofia Commerce-Pawn Brokerage AD 0.3378
SPDY Speedy AD 0.1010
SPH Stara Planina Hold AD 0.5935
FIB CB First Investment Bank AD 0.1107
CCB CB Central Cooperative Bank AD 0.1666
TBS Telelink Business Services Group AD 0.1304
TIB Telematic Interactive Bulgaria AD 0.0955
T57 Trace Group Hold AD 0.1877
WISR Wiser Technology AD 0.4774
BREF Bulgarian Real Estate Fund REIT 0.7428
HES Hydraulic Elements and Systems /HES/ AD 0.2029
CHIM Chimimport AD 0.2159
HVAR Holding Varna AD 0.3183
SLYG Shelly Group SE 0.3036
The free-float data on the issues of BGBX 40 presented herein are the median values for the period 02 December 2024 - 01 March 2025. Source: BSE (11.03.2025) |
| The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 2 at its session held on 10 March 2025:
III. With reference to item 8 of Appendix No. 3 (BG REIT Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BG REIT in effect from 24 March 2025:
BSE code Issuer Free-float factor
ATER Advance Terrafund REIT 0.6100
BSP Balkan and Sea Properties REIT 0.4126
CCBR Grand Vision Properties REIT 0.5092
RPF Roi Property Fund REIT 0.4088
SFB Sopharma Buildings REIT 0.2695
SBPF Super Borovetz Property Fund REIT 0.5465
BREF Bulgarian Real Estate Fund REIT 0.7428
The free-float data on the issues of BG REIT presented herein are the median values for the period 02 December 2024 - 01 March 2025.
IV. With reference to item 22 of the Rules for Calculating the BEAM Market Companies' Index (beamX), the Indices Committee adopted the following free-float factors of the issues comprising beamX in effect from 24 March 2025:
BSE code Issuer Free-float factor
ITF ITF Group AD 0.1148
BDT Biodit AD 0.1719
BLRN Boleron AD 0.2145
DRON Dronamics Capital AD 0.9400
HRC HR Capital JSC 0.1805
IMP ImPulse Growth AD 0.8507
IPSP IpoTech Sofcom AD 0.6219
PAY Paysera Bulgaria JSC 0.1627
SIN Sin Cars Industry AD 0.1228
WIN Webit Investment Network AD 0.8556
The free-float data on the issues of beamX presented herein are the median values for the period 02 December 2024 - 01 March 2025.
V. The Indices Committee will define the weight factors of the issues comprising the BSE Indices (including beamX) based on the closing prices on 21 March 2025.
VI. The next session of the Indices Committee, at which free-float factors of the issues comprising the BSE Indices (including beamX) are to be specified, shall be held on 02 June 2025, as these are to enter into force as of 23 June 2025. Source: BSE (11.03.2025) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT publishes Annual Financial Report for the activities of special purpose entities – ESEF format as of 31-12-2024. Source: BSE (26.03.2025) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for the first quarter of 2025. Source: BSE (02.05.2025) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT convenes a regular General Meeting of Shareholders on 26.06.2025 at 11:00 a.m. in Sofia, 5 Lachezar Stanchev Str., Sopharma Business Towers, Building A, floor 20, with the following agenda:
- Report of the management bodies on the company's activities in 2024;
- Adoption of the company's annual financial statements for 2024;
- Report of the registered auditor for 2024;
- Report of the Audit Committee for 2024;
- Report of the Investor Relations Director for 2024;
- Adoption of a report on the implementation of the Remuneration Policy for the members of the management bodies;
- Discharge of the members of the management bodies from liability for their activities in 2024;
- Election of a registered auditor for 2025;
- Adoption of a new Statute of the Audit Committee;
- Decision on the distribution of financial results. Draft decision: Does not distribute a dividend since the company ended 2024 with a negative financial result in the amount of BGN 91,693.58. Adopts a decision that the formed loss will be covered by the accumulated reserves from the Reserve Fund;
- Changes in the management bodies of the company. Draft decision: Re-elects the members of the Board of Directors Irina Mincheva, Emil Kostov and Stoycho Pangev, for a new term of 5 years;
- Determination of the amount of the remuneration of the members of the management bodies.
- Determination of the amount of the management guarantee for the members of the management bodies.
- Adoption of a decision under Art. 244, para. 7, s. 2 of the Commercial Act to authorize a person to conclude, on behalf and for the account of the company, contracts for the assignment of management with the members of the Board of Directors.
- In the absence of a quorum, the meeting will be held on 11.07.2025 at 11:00 a.m. at the same place and with the same agenda.
The right to vote in the General Meeting of Shareholders is exercised by the persons registered as such with the right to vote in the central securities register 14 days before the date of the General Meeting of Shareholders, or as of 12.06.2025.
The last date for concluding transactions with shares of this company on the Exchange, as a result of which the acquirer will be able to exercise the right to vote in the General Meeting of Shareholders, is 10.06.2025. Source: BSE (22.05.2025) |
| The BSE Indices Committee adopted the following decisions under Record of Proceedings No. 4 at its session held on 02 June 2025:
III. With reference to item 8 of Appendix No. 3 (BG REIT Calculation Methodology) to the Rules for Calculating the BSE Indices, the Indices Committee adopted the following free-float factors of the issues comprising BG REIT in effect from 23 June 2025:
BSE code Issuer Free-float factor
ATER Advance Terrafund REIT 0.6091
BSP Balkan and Sea Properties REIT 0.4112
CCBR Grand Vision Properties REIT 0.5094
RPF Roi Property Fund REIT 0.4089
SFB Sopharma Buildings REIT 0.2697
SBPF Super Borovetz Property Fund REIT 0.5464
BREF Bulgarian Real Estate Fund REIT 0.7428
The free-float data on the issues of BG REIT presented herein are the median values for the period 02 March 2025 - 01 June 2025.
IV. With reference to item 22 of the Rules for Calculating the BEAM Market Companies' Index (beamX), the Indices Committee adopted the following free-float factors of the issues comprising beamX in effect from 23 June 2025:
BSE code Issuer Free-float factor
BDT Biodit AD 0.1706
BLRN Boleron AD 0.2146
DRON Dronamics Capital AD 0.9400
HRC HR Capital JSC 0.1805
IMP ImPulse Growth AD 0.8487
IPSP IpoTech Sofcom AD 0.6219
ITF ITF Group AD 0.1148
PAY Paysera Bulgaria JSC 0.1627
SIN Sin Cars Industry AD 0.1228
WIN Webit Investment Network AD 0.8607
The free-float data on the issues of beamX presented herein are the median values for the period 02 March 2025 - 01 June 2025.
V. The Indices Committee will define the weight factors of the issues comprising the BSE Indices (including beamX) based on the closing prices on 20 June 2025.
VI. The next session of the Indices Committee, at which free-float factors of the issues comprising the BSE Indices (including beamX) are to be specified, shall be held on 02 September 2025, as these are to enter into force as of 23 September 2025. Source: BSE (03.06.2025) |
| Sopharma Buildings REIT (SFB)
Information on the decisions taken by the regular GMS held on 26 June 2025 Source: BSE (27.06.2025) |
| Sopharma Buildings REIT (SFB)
The regular General Meeting of Shareholders of Sopharma Buildings REIT, dated 26 June 2025, passed the following resolutions:
- Adoption of the 2024 activity report of the managing bodies
- Adoption of the 2024 annual financial report of the company
- Adoption of the report of the registered auditor on the verification of the 2024 annual financial report
- Adoption of the report of the Audit Committee for 2024
- Adoption of the report of the Investor Relations Director for 2024
- Adoption of the report on the implementation of the remuneration policy for the members of the managing bodies
- Release from liability of the members of the managing bodies for their activity in 2024
- Election of a registered auditor for 2025
- Adoption of a new statute of the Audit Committee
- No dividend distribution for 2024 due to realised loss of BGN 91,693.58, but covering the loss by funds of the company's accumulated reserves
- Re-election of Irina Mincheva, Emil Kostov and Stoycho Pangev as members of the Board of Directors with a new 5-year mandate
- Determination of the remuneration to the members of the managing bodies
- Determination of the guarantee for the management of the members of the managing bodies
- Authorisation of Irina Mincheva to sign the management agreements with the members of the Board of Directors on behalf and for the account of the company Source: BSE (30.06.2025) |
| Sopharma Buildings REIT (SFB)
Insider information under Art. 17 (1) in conjunction with Art. 7 of Regulation (EU) No. 596/2014 of the EP and the Council Source: BSE (15.07.2025) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented its quarterly report for the second quarter of 2025. Source: BSE (31.07.2025) |
| BSE Board of Directors adopted the following decisions under Record of Proceedings No. 70 of 09 September 2025:
II. Revision of the BGBX 40 index base
According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 15 of Appendix No. 2 (BGBX 40 Calculation Methodology), the BSE Board of Directors excluded the following three issues of shares from the BGBX 40 index base:
HIKA Industrial Capital Holding AD,
SNRG Synergon Holding AD, and
SFB Sopharma Buildings REIT;
And included the following four issues of shares in the BGBX 40 index base:
THQM Tchaikapharma High Quality Medicines AD,
HSI Sila Holding AD, and
ALCM Alcomet AD.
III. Revision of the BG REIT index base
According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 12 of Appendix No. 3 (BG REIT Calculation Methodology), the BSE Board of Directors excluded the following issue of shares from the BG REIT index base:
SFB Sopharma Buildings REIT;
And included the following issue of shares in the BG REIT index base:
CITP Premium Property Invest REIT.
IV. Revision of the BG TR30 index base
According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 17 of Appendix No. 4 (BG TR30 Calculation Methodology), the BSE Board of Directors excluded the following five issues of shares from the BG TR30 index base:
GR6 Gradus AD,
CAPM Capital Management SPV,
NEOH Neochim AD,
SPDY Speedy AD, and
SBPF Super Borovetz Property Fund REIT;
And included the following five issues of shares in the BG TR30 index base:
HSI Sila Holding AD,
TXIM CB Texim Bank AD,
TIB Telematic Interactive Bulgaria AD,
TCH TK-Hold PLC, and
HNVK Holding Nov Vek AD.
V. Revision of the beamX index base
According to Art. 15, item 4 of the Rules for Calculating the BSE Indices in conjunction with item 20 of the Rules for Calculating the beam Market Companies' Index (beamX), the BSE Board of Directors excluded the following issue of shares from the beamX index base:
IPSP IpoTech Sofcom AD,
And included the following issue of shares in the beamX index base:
GGS Global Gaming Solutions AD.
The amendments to the above index bases will become effective on 23 September 2025. Source: BSE (10.09.2025) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented its quarterly report for the Third Quarter of 2025. Source: BSE (31.10.2025) |
| "Sopharma Buildings" REIT has concluded with "DSK Bank" AD a Standard Investment Loan Agreement in the amount of 28,121,000 euros, the special purpose vehicle announced. The document was signed on January 21. The loan will be used to finance/refinance, excluding VAT, expenses related to the acquisition and commissioning of "Residential buildings with shops, a kindergarten, underground garages and above-ground parking spaces - Stage I", under construction on its own land in Sofia, 3 Kliment Ohridski Blvd. The loan bears annual interest on regular principal, formed by a variable reference interest rate, representing a weighted average deposit index (WADI) plus an agreed premium of 3.5 percent. The drawdown period is until December 31, 2027, with a grace period on the principal until March 31, 2028 and a repayment deadline of December 31, 2028. On January 21, Sopharma Buildings concluded an annex to the Standard Investment Loan Agreement signed on December 4, 2024 between Sopharma Buildings and DSK Bank AD. This annex changes the amount of the annual interest on the regular principal of the loan, formed by a variable reference interest rate, representing a weighted average deposit index plus an agreed premium, as the agreed premium is reduced from 4.9% to 3.5%. Sopharma AD is the largest shareholder with 32.71% of the capital. Source: Banker (23.01.2026) |
| Sopharma Buildings REIT (SFB)
Notification of a signed annex on 21 January 2026 to the standard investment loan agreement with CB DSK Bank dated 04 December 2024 Source: BSE (23.01.2026) |
| Sopharma Buildings REIT (SFB)
Notification of a signed on 21 January 2026 standard investment loan agreement for EUR 28,121,000 with CB DSK Bank Source: BSE (23.01.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for the Fourth Quarter of 2025. Source: BSE (30.01.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for the Fourth Quarter of 2025. Source: BSE (30.01.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT publishes Annual Individual Financial Statement for the year ended 31-12-2025. Source: BSE (10.03.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT informs that on 27.04.2026 it finalized a transaction for the sale of its own real estate located in the city of Burgas. Source: BSE (28.04.2026) |
| At its meeting on 28.04.2026, the FSC decided:
1. To issue a license to "Bilar" EOOD to operate as a crypto-asset service provider. The company has the right to provide crypto-asset services as follows:
– provision of custody and administration of crypto-assets on behalf of clients;
– execution of orders related to crypto-assets on behalf of clients;
– provision of portfolio management related to crypto-assets.
2. Approves Milen Keremedchiev as a new member of the board of directors of "Fond Imoti" REIT.
3. Approves the submitted changes to the articles of association of "Sopharma Buildings" REIT.
4. Deletes the registration of the Bulgarian Stock Exchange AD as a benchmark administrator and removes the company from the register of benchmark administrators licensed or registered by the Commission under Regulation (EU) 2016/1011.
7. Terminates the proceedings in connection with the issuance of approval to a new member of the board of directors of the management company Thracian Invest EAD.
8. Exempts for 2026 Aurubis Bulgaria AD from the obligation to obtain a license as an investment intermediary in connection with the company's trading in commodity derivatives or emission allowances or their derivatives (within the meaning of Art. 5 of the MFIA).
9. Sends a letter to FF Digital EOOD requesting additional information and documents in connection with the issuance of a permit to operate as a crypto-asset service provider. Source: Company information (29.04.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT presented quarterly report for Q1 2026. Source: BSE (04.05.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT convenes a regular General Meeting of Shareholders on 18.06.2026 at 11:00 a.m. in Sofia, 5 Lachezar Stanchev Str., Sopharma Business Towers Complex, Building A, floor 20, with the following agenda:
- Report of the management bodies on the company's activities in 2025;
- Adoption of the company's annual financial statements for 2025;
- Report of the registered auditor for 2025;
- Report of the audit committee for 2025;
- Report of the Investor Relations Director for 2025;
- Adoption of a report on the implementation of the Remuneration Policy for the members of the management bodies;
- Discharge of the members of the management bodies from liability for their activities in 2025;
- Election of a registered auditor for 2026;
- Changes in the audit committee and determination of the remuneration of its members;
- Changes in the company's articles of association;
- Decision on the distribution of financial results. Draft decision: No dividend is distributed, since the company ended the reporting year 2025 with a negative financial result in the amount of BGN 233,772.40, and after its transformation in accordance with Art. 29, para. 3 of the Act on the Formation of Companies and the Transfer of Assets and Liabilities – a loss in the amount of BGN 756,956.03. The formed loss for 2025, in the amount of EUR 119,525.93, shall be covered by the accumulated reserves from the Reserve Fund;
- Determination of the amount of remuneration of the members of the management bodies.
- Adoption of changes in the policy for the remuneration of the members of the management bodies.
- In the absence of a quorum, the meeting will be held on 03.07.2026 at 11.00 a.m. at the same place and with the same agenda.
The right to vote at the GMS is exercised by the persons registered as such with the right to vote in the central securities register 14 days before the date of the GMS, or as of 04.06.2026.
The last date for concluding transactions with shares of this company on the Exchange, as a result of which the acquirer will be able to exercise the right to vote at the GMS, is 02.06.2026 (Ex-Date: 03.06.2026) Source: BSE (19.05.2026) |
| Sopharma Buildings REIT (SFB)
Announcement of decisions adopted at the regular AGM held on 18.06.2026 Source: BSE (19.06.2026) |
| Sopharma Buildings REIT (SFB)
At the regular General Meeting of Shareholders of Sopharma Buildings REIT held on 18.06.2026, the following decisions were made:
- Adopts the report of the management bodies on the company's activities in 2025;
- Adopts the annual financial statement of the company for 2025;
- Adopts the report of the registered auditor on the audit of the annual
- Adopts the report of the audit committee for 2025;
- Adopts the report of the director of investor relations for 2025;
- Adopts the report on the implementation of the policy on the remuneration of the members of the management bodies;
- Discharges the members of the management bodies from liability for their activities in 2025;
- Determines the amount of the remuneration of the members of the management bodies;
- Elects a registered auditor for 2026;
- Adopts changes in the audit committee and determination of the remuneration of its members
- Adopts changes in the policy for the remuneration of the members of the management bodies.
- Adopts changes in the company's articles of association;
- Decision on the distribution of financial results. Does not distribute a dividend, since the company ended the reporting year 2025 with a negative financial result in the amount of BGN 233,772.40, and after its transformation in accordance with Art. 29, para. 3 of the Act on the Formation of Private Companies – a loss in the amount of BGN 756,956.03. The formed loss for 2025, in the amount of EUR 119,525.93, shall be covered by the accumulated reserves from the Reserve Fund; Source: BSE (19.06.2026) |
| Ñîôàðìà áèëäèíãñ ÀÄÑÈÖ (SFB)
Ñîôàðìà áèëäèíãñ ÀÄÑÈÖ ïðåäñòàâè òðèìåñå÷åí îò÷åò çà Âòîðî òðèìåñå÷èå íà 2026 ã. Source: BSE (31.07.2026) |
| At a meeting of the Bulgarian Stock Exchange Index Commission, under Minutes No. 8 of 08.09.2026, the following decisions were made:
III. In connection with item 8 of Appendix No. 3 (Methodology for calculating BG REIT) to the Rules for calculating indices of the Bulgarian Stock Exchange, the Index Commission determines the following free-float coefficients for the issues included in the BG REIT base, which will enter into force as of 21.09.2026:
Stock code Issuer Free-float coefficient
ATER Advance Terrafund REIT 0.6081
BSP Balkan & Sea Properties REIT 0.4110
CCBR Grand Vision Properties REIT 0.5092
RPF Roy Property Fund REIT 0.4600
SFB Sopharma Buildings REIT 0.2701
SBPF Super Borovets Property Fund REIT 0.5481
BREF Bulgaria Real Estate Fund REIT 0.7366
The free float data for BG REIT issues is the median value for the period from 02.06.2026 to 01.09.2026
IV. In connection with item 22 of the Rules for calculating the index of companies on the beam market (beamX), the Index Commission determines the following free-float coefficients for the issues included in the beamX database, which will enter into force as of 21.09.2026:
Stock code Issuer Free-float coefficient
ITF ITF Group AD 0.1148
BDT Biodit AD 0.1706
BLRN Boleron AD 0.2145
DRON Dronamix Capital AD 0.9492
HRC HR Capital AD 0.1820
IMP Impulse Growth AD 0.8707
IPSP IpoTech Sofcom AD 0.5957
MFG MFG Invest AD 0.1300
PAY Peysera Bulgaria AD 0.2170
WIN Webbit Investment Network AD 0.8925
The free-float data of the issues from beamX is a median value for the period from 02.06.2026 to 01.09.2026.
V. In connection with item 15 of the Rules for calculating the index of companies with good corporate governance CGIX, the Index Commission determines the following free-float coefficients of the issues included in the CGIX base, which will enter into force as of 21.09.2026.
Stock code Issuer Free-float coefficient
AGH Agria Group Holding AD 0.1860
BSE Bulgarian Stock Exchange AD 0.4995
DUH Doverie United Holding AD 0.6376
SIRM Sirma Group AD 0.5988
SFA Sopharma AD 0.3390
CCB TB Central Cooperative Bank AD 0.1666
SLYG Shelly Group ED 0.2866
The free-float data for CGIX issues is a median value for the period from 02.06.2026 to 01.09.2026
VI. The Index Commission will determine the weighting factors of the issues included in the BSE index bases (including the beam market companies index) and the CGIX index based on the respective "closing" prices as of 18.09.2026
VII. The next meeting of the Index Commission, at which free-float coefficients of the issues included in the BSE indices (including the index of companies on the beam market) and the CGIX index will be determined, will be held on 02.12.2026, and these coefficients will enter into force as of 21.12.2026. Source: BSE (09.09.2026) |
| Sopharma Buildings REIT (SFB)
Sopharma Buildings REIT has submitted its quarterly report for the third quarter of 2026. Source: BSE (30.10.2026) |
| Sopharma Buildings REIT (SFB)
On November 16, 2026, Sopharma Buildings REIT finalized a transaction for the sale of its own real estate, in accordance with a decision by the Board of Directors dated October 23, 2026. Source: BSE (17.11.2026) |